PedAM

Pediatric Disease Annotations & Medicines


	follicular lymphoma

Disease ID	26
Disease	follicular lymphoma
Definition	Malignant lymphoma in which the lymphomatous cells are clustered into identifiable nodules within the LYMPH NODES. The nodules resemble to some extent the GERMINAL CENTER of lymph node follicles and most likely represent neoplastic proliferation of lymph node-derived follicular center B-LYMPHOCYTES.
Synonym	(nodular lymphoma: brill-symmers disease) or (reticulosarcoma - follicular or nodular) (nodular lymphoma: brill-symmers disease) or (reticulosarcoma - follicular or nodular) (disorder) [m]brill - symmers' disease [m]follicular lymphosarcoma nos [m]giant follicular lymphoma [m]malignant lymphoma, centroblastic-centrocytic, follicular [m]malignant lymphoma, centroblastic-centrocytic, follicular (morphologic abnormality) [m]malignant lymphoma, nodular nos [m]malignant lymphoma, nodular nos (& [brill - symmers' disease]) [m]malignant lymphoma, nodular nos (& [brill - symmers' disease]) (disorder) [m]malignant lymphoma, nodular nos (morphologic abnormality) [m]nodular lymphosarcoma nos brill - symmers' disease brill symmers dis brill symmers disease brill-symmers disease disease, brill-symmers follic lymphoma follic lymphoma giant follicle center lymphoma follicular centre cell lymphoma follicular low grade b-cell lymphoma follicular low grade b-cell lymphoma (disorder) follicular lymphoma (morphologic abnormality) follicular lymphoma nos follicular lymphoma, giant follicular lymphoma: [non-hodgkin's] or [nos] follicular lymphoma: [non-hodgkin's] or [nos] (disorder) follicular lymphomas follicular lymphomas, giant follicular lymphosarcoma follicular non-hodgkin lymphoma follicular non-hodgkin's lymphoma follicular non-hodgkin's lymphoma (disorder) germinoblastoma, follicular giant follic lymphoma giant follicular lymphoma giant follicular lymphomas giant follicular lymphosarcoma lymphoma follic lymphoma follicular lymphoma giant follic lymphoma, follicular lymphoma, follicular [disease/finding] lymphoma, follicular centre cell lymphoma, follicular, malignant lymphoma, giant follicular lymphoma, nodular lymphomas, follicular lymphomas, giant follicular lymphomas, nodular lymphosarcoma follicular malignant lymphoma, centroblastic-centrocytic, follicular malignant lymphoma, centroblastic-centrocytic, follicular (disorder) malignant lymphoma, centroblastic-centrocytic, follicular (morphologic abnormality) malignant lymphoma, centroblastic-centrocytic, follicular -retired- malignant lymphoma, follicle center malignant lymphoma, follicle center, follicular malignant lymphoma, follicle centre malignant lymphoma, follicle centre, follicular malignant lymphoma, follicular malignant lymphoma, follicular, nos malignant lymphoma, lymphocytic, nodular malignant lymphoma, lymphocytic, nodular, nos malignant lymphoma, nodular malignant lymphoma, nodular, nos nodular lymphocytic lymphoma nodular lymphoma nodular lymphoma (brill - symmers disease) nodular lymphoma (disorder) nodular lymphoma nos nodular lymphoma nos (disorder) nodular lymphoma of unspecified site nodular lymphoma of unspecified site (disorder) nodular lymphomas nodular lymphosarcoma nodular malignant lymphoma reticulosarcoma - follicular or nodular
Orphanet	ORPHANET:545
DOID	DOID:8524
UMLS	C0024301
MeSH	D008224
SNOMED-CT	SNOMEDCT_US_2016_09_01:277618009;SNOMEDCT_US_2016_09_01:307637005;SNOMEDCT_US_2016_09_01:308121000;SNOMEDCT_US_2016_09_01:269476000
Comorbidity	UMLS \| Disease \| Sentences' Count(Total Sentences:46) C0024299 \| lymphoma \| 17 C0024299 \| lymphomas \| 8 C0079731 \| b-cell lymphoma \| 4 C0019829 \| hodgkin's lymphoma \| 2 C0030807 \| pemphigus \| 2 C0079744 \| diffuse large b-cell lymphoma \| 2 C0019829 \| hodgkin lymphoma \| 2 C0079731 \| b-cell lymphomas \| 2 C0334634 \| mantle cell lymphoma \| 2 C0024305 \| non-hodgkin lymphoma \| 2 C0009319 \| colitis \| 1 C0024305 \| non-hodgkin's lymphoma \| 1 C0041234 \| chagas disease \| 1 C0079731 \| b-cell non-hodgkin lymphoma \| 1 C0079734 \| diffuse lymphoma \| 1 C1704214 \| xanthogranuloma \| 1 C0037889 \| hereditary spherocytosis \| 1 C0006277 \| bronchitis \| 1 C0006142 \| breast cancer \| 1 C0039101 \| synovial sarcoma \| 1 C0152025 \| polyneuropathy \| 1 C0019163 \| hepatitis b \| 1 C0019158 \| hepatitis \| 1 C0281963 \| red cell aplasia \| 1 C0011991 \| diarrhea \| 1 C0151313 \| sensory neuropathy \| 1 C0001418 \| adenocarcinoma \| 1 C0024419 \| macroglobulinemia \| 1 C0042345 \| varices \| 1 C0034902 \| pure red cell aplasia \| 1 C0001815 \| myelofibrosis \| 1 C0010346 \| crohn's disease \| 1 C0042721 \| viral hepatitis \| 1 C0037753 \| sparganosis \| 1 C0949272 \| ileocolitis \| 1 C0341335 \| cmv colitis \| 1 C0442874 \| neuropathy \| 1 C0024623 \| stomach cancer \| 1 C0043324 \| juvenile xanthogranuloma \| 1 C1261473 \| sarcoma \| 1 C0007104 \| carcinoma of the breast \| 1 C0024623 \| gastric cancer \| 1 C0019163 \| viral hepatitis b \| 1 C1134719 \| invasive ductal carcinoma of the breast \| 1 C0040053 \| thrombus \| 1 C0001339 \| acute pancreatitis \| 1
Curated Gene	Entrez_id \| Symbol \| Resource(Total Genes:22) HLA-DRB1 \| 3123 \| ORPHANET BCL2 \| 596 \| CTD_human;ORPHANET BCL6 \| 604 \| ORPHANET MYD88 \| 4615 \| CTD_human EZH2 \| 2146 \| CTD_human EBF1 \| 1879 \| CTD_human TNFAIP3 \| 7128 \| CTD_human CREBBP \| 1387 \| CTD_human TYMS \| 7298 \| CTD_human KMT2D \| 8085 \| CTD_human IFNA2 \| 3440 \| CTD_human BCL10 \| 8915 \| CLINVAR MTHFR \| 4524 \| CTD_human PVT1 \| 5820 \| GWASCAT SLC14A2 \| 8170 \| GWASCAT CD86 \| 942 \| GWASCAT IGH \| 3492 \| ORPHANET MTR \| 4548 \| CTD_human GRAMD1B \| 57476 \| GWASCAT KDSR \| 2531 \| CTD_human LPP \| 4026 \| GWASCAT C17orf62 \| 79415 \| GWASCAT
Inferring Gene	Entrez_id \| Symbol \| Resource(Total Genes:11) 604 \| BCL6 \| infer 596 \| BCL2 \| infer 958 \| CD40 \| infer 8837 \| CFLAR \| infer 2212 \| FCGR2A \| infer 2214 \| FCGR3A \| infer 2215 \| FCGR3B \| infer 285834 \| HCG22 \| infer 3119 \| HLA-DQB1 \| infer 4524 \| MTHFR \| infer 7157 \| TP53 \| infer
Text Mined Gene	Entrez_id \| Symbol \| Score \| Resource(Total Genes:298) 933 \| CD22 \| DISEASES 3385 \| ICAM3 \| DISEASES 100271849 \| MEF2B \| DISEASES 602 \| BCL3 \| DISEASES 3566 \| IL4R \| DISEASES 4616 \| GADD45B \| DISEASES 6367 \| CCL22 \| DISEASES 55824 \| PAG1 \| DISEASES 10535 \| RNASEH2A \| DISEASES 10148 \| EBI3 \| DISEASES 973 \| CD79A \| DISEASES 1440 \| CSF3 \| DISEASES 952 \| CD38 \| DISEASES 3558 \| IL2 \| DISEASES 6688 \| SPI1 \| DISEASES 595 \| CCND1 \| DISEASES 57379 \| AICDA \| DISEASES 1611 \| DAP \| DISEASES 3565 \| IL4 \| DISEASES 604 \| BCL6 \| DISEASES 6402 \| SELL \| DISEASES 7128 \| TNFAIP3 \| DISEASES 5217 \| PFN2 \| DISEASES 4801 \| NFYB \| DISEASES 3228 \| HOXC12 \| DISEASES 8744 \| TNFSF9 \| DISEASES 1236 \| CCR7 \| DISEASES 968 \| CD68 \| DISEASES 482 \| ATP1B2 \| DISEASES 599 \| BCL2L2 \| DISEASES 56112 \| PCDHGA3 \| DISEASES 6382 \| SDC1 \| DISEASES 4064 \| CD180 \| DISEASES 4853 \| NOTCH2 \| DISEASES 57498 \| KIDINS220 \| DISEASES 1794 \| DOCK2 \| DISEASES 60468 \| BACH2 \| DISEASES 4005 \| LMO2 \| DISEASES 3557 \| IL1RN \| DISEASES 8737 \| RIPK1 \| DISEASES 29121 \| CLEC2D \| DISEASES 7188 \| TRAF5 \| DISEASES 904 \| CCNT1 \| DISEASES 5689 \| PSMB1 \| DISEASES 7528 \| YY1 \| DISEASES 945 \| CD33 \| DISEASES 1387 \| CREBBP \| DISEASES 9620 \| CELSR1 \| DISEASES 5264 \| PHYH \| DISEASES 3682 \| ITGAE \| DISEASES 2033 \| EP300 \| DISEASES 330 \| BIRC3 \| DISEASES 943 \| TNFRSF8 \| DISEASES 60482 \| SLC5A7 \| DISEASES 941 \| CD80 \| DISEASES 54940 \| OCIAD1 \| DISEASES 59067 \| IL21 \| DISEASES 7535 \| ZAP70 \| DISEASES 29999 \| FSCN3 \| DISEASES 8379 \| MAD1L1 \| DISEASES 3189 \| HNRNPH3 \| DISEASES 939 \| CD27 \| DISEASES 3687 \| ITGAX \| DISEASES 1039 \| CDR2 \| DISEASES 3394 \| IRF8 \| DISEASES 10349 \| ABCA10 \| DISEASES 7157 \| TP53 \| DISEASES 207 \| AKT1 \| DISEASES 8915 \| BCL10 \| DISEASES 2212 \| FCGR2A \| DISEASES 83417 \| FCRL4 \| DISEASES 4794 \| NFKBIE \| DISEASES 526 \| ATP6V1B2 \| DISEASES 29967 \| LRP12 \| DISEASES 1030 \| CDKN2B \| DISEASES 3439 \| IFNA1 \| DISEASES 472 \| ATM \| DISEASES 2321 \| FLT1 \| DISEASES 2838 \| GPR15 \| DISEASES 23460 \| ABCA6 \| DISEASES 7345 \| UCHL1 \| DISEASES 10563 \| CXCL13 \| DISEASES 9131 \| AIFM1 \| DISEASES 1844 \| DUSP2 \| DISEASES 909 \| CD1A \| DISEASES 3588 \| IL10RB \| DISEASES 11189 \| CELF3 \| DISEASES 115650 \| TNFRSF13C \| DISEASES 2063 \| NR2F6 \| DISEASES 6294 \| SAFB \| DISEASES 643 \| CXCR5 \| DISEASES 114757 \| CYGB \| DISEASES 6154 \| RPL26 \| DISEASES 6886 \| TAL1 \| DISEASES 2215 \| FCGR3B \| DISEASES 5966 \| REL \| DISEASES 3600 \| IL15 \| DISEASES 1437 \| CSF2 \| DISEASES 819 \| CAMLG \| DISEASES 5896 \| RAG1 \| DISEASES 6778 \| STAT6 \| DISEASES 7083 \| TK1 \| DISEASES 598 \| BCL2L1 \| DISEASES 9963 \| SLC23A1 \| DISEASES 613 \| BCR \| DISEASES 51237 \| MZB1 \| DISEASES 1493 \| CTLA4 \| DISEASES 171558 \| PTCRA \| DISEASES 1901 \| S1PR1 \| DISEASES 25998 \| IBTK \| DISEASES 5581 \| PRKCE \| DISEASES 3913 \| LAMB2 \| DISEASES 57507 \| ZNF608 \| DISEASES 27087 \| B3GAT1 \| DISEASES 695 \| BTK \| DISEASES 3265 \| HRAS \| DISEASES 947 \| CD34 \| DISEASES 836 \| CASP3 \| DISEASES 10007 \| GNPDA1 \| DISEASES 924 \| CD7 \| DISEASES 8636 \| SSNA1 \| DISEASES 4179 \| CD46 \| DISEASES 3078 \| CFHR1 \| DISEASES 2629 \| GBA \| DISEASES 168537 \| GIMAP7 \| DISEASES 30835 \| CD209 \| DISEASES 7298 \| TYMS \| DISEASES 4261 \| CIITA \| DISEASES 23512 \| SUZ12 \| DISEASES 4026 \| LPP \| DISEASES 6470 \| SHMT1 \| DISEASES 56776 \| FMN2 \| DISEASES 27086 \| FOXP1 \| DISEASES 10892 \| MALT1 \| DISEASES 2146 \| EZH2 \| DISEASES 8289 \| ARID1A \| DISEASES 197322 \| ACSF3 \| DISEASES 9242 \| MSC \| DISEASES 6664 \| SOX11 \| DISEASES 81611 \| ANP32E \| DISEASES 951 \| CD37 \| DISEASES 3563 \| IL3RA \| DISEASES 8784 \| TNFRSF18 \| DISEASES 706 \| TSPO \| DISEASES 1850 \| DUSP8 \| DISEASES 596 \| BCL2 \| DISEASES 3009 \| HIST1H1B \| DISEASES 9021 \| SOCS3 \| DISEASES 942 \| CD86 \| DISEASES 7127 \| TNFAIP2 \| DISEASES 6472 \| SHMT2 \| DISEASES 151888 \| BTLA \| DISEASES 5133 \| PDCD1 \| DISEASES 1033 \| CDKN3 \| DISEASES 327657 \| SERPINA9 \| DISEASES 6622 \| SNCA \| DISEASES 23583 \| SMUG1 \| DISEASES 53335 \| BCL11A \| DISEASES 3266 \| ERAS \| DISEASES 3805 \| KIR2DL4 \| DISEASES 166824 \| RASSF6 \| DISEASES 89857 \| KLHL6 \| DISEASES 4306 \| NR3C2 \| DISEASES 921 \| CD5 \| DISEASES 10181 \| RBM5 \| DISEASES 55975 \| KLHL7 \| DISEASES 7517 \| XRCC3 \| DISEASES 53827 \| FXYD5 \| DISEASES 4033 \| LRMP \| DISEASES 8764 \| TNFRSF14 \| DISEASES 355 \| FAS \| DISEASES 9260 \| PDLIM7 \| DISEASES 219844 \| HYLS1 \| DISEASES 1612 \| DAPK1 \| DISEASES 5079 \| PAX5 \| DISEASES 841 \| CASP8 \| DISEASES 2213 \| FCGR2B \| DISEASES 2526 \| FUT4 \| DISEASES 9332 \| CD163 \| DISEASES 5336 \| PLCG2 \| DISEASES 3635 \| INPP5D \| DISEASES 79947 \| DHDDS \| DISEASES 6693 \| SPN \| DISEASES 4311 \| MME \| DISEASES 54106 \| TLR9 \| DISEASES 2475 \| MTOR \| DISEASES 7096 \| TLR1 \| DISEASES 57713 \| SFMBT2 \| DISEASES 4548 \| MTR \| DISEASES 4751 \| NEK2 \| DISEASES 1378 \| CR1 \| DISEASES 1380 \| CR2 \| DISEASES 5788 \| PTPRC \| DISEASES 56956 \| LHX9 \| DISEASES 51022 \| GLRX2 \| DISEASES 84824 \| FCRLA \| DISEASES 2214 \| FCGR3A \| DISEASES 4332 \| MNDA \| DISEASES 115350 \| FCRL1 \| DISEASES 6016 \| RIT1 \| DISEASES 4288 \| MKI67 \| DISEASES 388697 \| HRNR \| DISEASES 4170 \| MCL1 \| DISEASES 639 \| PRDM1 \| DISEASES 143384 \| CACUL1 \| DISEASES 2045 \| EPHA7 \| DISEASES 914 \| CD2 \| DISEASES 1847 \| DUSP5 \| DISEASES 537 \| ATP6AP1 \| DISEASES 257 \| ALX3 \| DISEASES 10360 \| NPM3 \| DISEASES 11146 \| GLMN \| DISEASES 959 \| CD40LG \| DISEASES 541466 \| CT45A1 \| DISEASES 8880 \| FUBP1 \| DISEASES 4919 \| ROR1 \| DISEASES 5236 \| PGM1 \| DISEASES 1791 \| DNTT \| DISEASES 5728 \| PTEN \| DISEASES 958 \| CD40 \| DISEASES 896 \| CCND3 \| DISEASES 64121 \| RRAGC \| DISEASES 1043 \| CD52 \| DISEASES 79695 \| GALNT12 \| DISEASES 7027 \| TFDP1 \| DISEASES 9696 \| CROCC \| DISEASES 6850 \| SYK \| DISEASES 3055 \| HCK \| DISEASES 10673 \| TNFSF13B \| DISEASES 50943 \| FOXP3 \| DISEASES 4524 \| MTHFR \| DISEASES 386653 \| IL31 \| DISEASES 3604 \| TNFRSF9 \| DISEASES 5101 \| PCDH9 \| DISEASES 4609 \| MYC \| DISEASES 5111 \| PCNA \| DISEASES 3559 \| IL2RA \| DISEASES 3440 \| IFNA2 \| DISEASES 57393 \| TMEM27 \| DISEASES 833 \| CARS \| DISEASES 3662 \| IRF4 \| DISEASES 286530 \| P2RY8 \| DISEASES 9946 \| CRYZL1 \| DISEASES 29126 \| CD274 \| DISEASES 399 \| RHOH \| DISEASES 6624 \| FSCN1 \| DISEASES 81623 \| DEFB126 \| DISEASES 238 \| ALK \| DISEASES 8812 \| CCNK \| DISEASES 340152 \| ZC3H12D \| DISEASES 974 \| CD79B \| DISEASES 5450 \| POU2AF1 \| DISEASES 145270 \| PRIMA1 \| DISEASES 10018 \| BCL2L11 \| DISEASES 10840 \| ALDH1L1 \| DISEASES 347734 \| SLC35B2 \| DISEASES 145957 \| NRG4 \| DISEASES 83478 \| ARHGAP24 \| DISEASES 6387 \| CXCL12 \| DISEASES 84433 \| CARD11 \| DISEASES 80380 \| PDCD1LG2 \| DISEASES 3119 \| HLA-DQB1 \| DISEASES 8115 \| TCL1A \| DISEASES 2531 \| KDSR \| DISEASES 83873 \| GPR61 \| DISEASES 7852 \| CXCR4 \| DISEASES 154810 \| AMOTL1 \| DISEASES 3120 \| HLA-DQB2 \| DISEASES 1029 \| CDKN2A \| DISEASES 6660 \| SOX5 \| DISEASES 960 \| CD44 \| DISEASES 7124 \| TNF \| DISEASES 51755 \| CDK12 \| DISEASES 6304 \| SATB1 \| DISEASES 5795 \| PTPRJ \| DISEASES 1018 \| CDK3 \| DISEASES 10672 \| GNA13 \| DISEASES 7072 \| TIA1 \| DISEASES 4615 \| MYD88 \| DISEASES 51014 \| TMED7 \| DISEASES 3925 \| STMN1 \| DISEASES 3586 \| IL10 \| DISEASES 135656 \| DPCR1 \| DISEASES 4193 \| MDM2 \| DISEASES 257144 \| GCSAM \| DISEASES 4603 \| MYBL1 \| DISEASES 55819 \| RNF130 \| DISEASES 100423062 \| IGLL5 \| DISEASES 5452 \| POU2F2 \| DISEASES 930 \| CD19 \| DISEASES 785 \| CACNB4 \| DISEASES 9 \| NAT1 \| DISEASES 605 \| BCL7A \| DISEASES 567 \| B2M \| DISEASES 7716 \| VEZF1 \| DISEASES 9294 \| S1PR2 \| DISEASES 407975 \| MIR17HG \| DISEASES 387066 \| SNHG5 \| DISEASES
Locus	Symbol \| Locus(Total Locus:4) BCL2 \| 18q21.33 IGH \| 14q32.33 BCL6 \| 3q27.3 HLA-DRB1 \| 6p21.32

Disease ID	26
Disease	follicular lymphoma
Integrated Phenotype	HPO \| Name(Total Integrated Phenotypes:13) HP:0001945 \| Fever HP:0002665 \| Lymphoma HP:0002585 \| Abnormality of the peritoneum HP:0001287 \| Meningitis HP:0001824 \| Weight loss HP:0012378 \| Fatigue HP:0001744 \| Splenomegaly HP:0200036 \| Skin nodule HP:0002202 \| Pleural effusion HP:0001004 \| Lymphedema HP:0030166 \| Night sweats HP:0100721 \| Mediastinal lymphadenopathy HP:0002716 \| Lymphadenopathy
Text Mined Phenotype	HPO \| Name \| Sentences' Count(Total Phenotypes:29) HP:0002665 \| Lymphoma \| 17 HP:0002664 \| Neoplasia \| 8 HP:0012189 \| Hodgkin disease \| 4 HP:0012191 \| B-cell lymphoma \| 4 HP:0012539 \| Non-Hodgkin lymphoma \| 2 HP:0012387 \| Bronchitis \| 1 HP:0001541 \| Ascites \| 1 HP:0001880 \| Eosinophilia \| 1 HP:0003002 \| Breast carcinoma \| 1 HP:0012410 \| Pure red cell aplasia \| 1 HP:0001289 \| Confusion \| 1 HP:0100242 \| Sarcoma \| 1 HP:0012570 \| Synovial sarcoma \| 1 HP:0001271 \| Polyneuropathy \| 1 HP:0000763 \| Sensory neuropathy \| 1 HP:0012223 \| Ruptured spleen \| 1 HP:0100280 \| Morbus Crohn \| 1 HP:0004313 \| Decreased immunoglobulin level \| 1 HP:0012126 \| Gastric cancer \| 1 HP:0002014 \| Diarrhea \| 1 HP:0200034 \| Papule \| 1 HP:0010784 \| Uterine tumor \| 1 HP:0011974 \| Myelofibrosis \| 1 HP:0012115 \| Liver inflammation \| 1 HP:0002583 \| Colitis \| 1 HP:0001735 \| Acute pancreatitis \| 1 HP:0006562 \| Viral hepatitis \| 1 HP:0011458 \| Abdominal symptom \| 1 HP:0004444 \| Spherocytosis \| 1

Disease ID	26
Disease	follicular lymphoma
Manually Symptom	UMLS \| Name(Total Manually Symptoms:12) C1963234 \| serum sickness C1536010 \| lymphoma transformation C1516669 \| clonal evolution C1112570 \| paraneoplastic pemphigus C0598766 \| lymphomagenesis C0392610 \| acquired prothrombin deficiency C0276652 \| cutaneous aspergillosis C0033680 \| protein losing enteropathy C0023524 \| progressive multifocal leukoencephalopathy C0019618 \| histiocytosis C0006105 \| brain abscess C0005699 \| blast crisis
Text Mined Symptom	UMLS \| Name \| Sentences' Count(Total Symptoms:1) C1112570 \| paraneoplastic pemphigus \| 2

Manually Genotype(Total Text Mining Genotypes:0)
(Waiting for update.)

All Snps(Total Genotypes:159)
snpId	pubmedId	geneId	geneSymbol	diseaseId	sourceId	sentence	score	Year	geneSymbol_dbSNP	CHROMOSOME	POS	REF	ALT
rs10484561	23025665	3126	HLA-DRB4	umls:C0024301	BeFree	In recent genome-wide association studies (GWAS) of FL, several genetic susceptibility loci have been identified on chromosome 6p21.33 (rs6457327) and 6p21.32 (rs10484561, rs2647012) in the human leukocyte antigen class I and class II regions.	0.001085767	2012	NA	6	32697643	T	G
rs10484561	20639881	3119	HLA-DQB1	umls:C0024301	GAD	[Genome-wide association study of follicular lymphoma identifies a risk locus at 6p21.32.]	0.005276948	2010	NA	6	32697643	T	G
rs10484561	22911334	266629	SEC14L3	umls:C0024301	BeFree	The TAP2 SNP was strongly associated with follicular lymphoma (FL, OR = 1.82, 95%CI 1.46-2.26; p = 6.9 × 10(-8)), and was independent of other known loci (rs10484561 and rs2647012) from this region.	0.000271442	2012	NA	6	32697643	T	G
rs1056503	25178586	5887	RAD23B	umls:C0024301	BeFree	The following genotypes in combination with hair dye use before 1980 were associated with FL risk: BRCA2 rs144848 AC+CC [odds ratio (OR) (95% confidence interval (CI)) 3.28(1.27-8.50)], WRN rs1346044 TT [OR(95% CI) 2.70(1.30-5.65)], XRCC3 rs861539 CT+TT [OR(95% CI) 2.76(1.32-5.77)], XRCC4 rs1805377 GG [OR(95% CI) 2.07(1.10-3.90)] and rs1056503 TT [OR(95% CI) 2.17(1.16-4.07)], ERCC1 rs3212961 CC [OR(95% CI) 1.93(1.00-3.72)], RAD23B rs1805329 CC [OR(95% CI) 2.28(1.12-4.64)], and MGMT rs12917 CC, rs2308321 AA, and rs2308327 AA genotypes [OR(95% CI) 1.96(1.06-3.63), 2.02(1.09-3.75), and 2.23(1.16-4.29), respectively].	0.002638474	2014	XRCC4	5	83353158	T	A,G
rs1056503	25178586	7517	XRCC3	umls:C0024301	BeFree	The following genotypes in combination with hair dye use before 1980 were associated with FL risk: BRCA2 rs144848 AC+CC [odds ratio (OR) (95% confidence interval (CI)) 3.28(1.27-8.50)], WRN rs1346044 TT [OR(95% CI) 2.70(1.30-5.65)], XRCC3 rs861539 CT+TT [OR(95% CI) 2.76(1.32-5.77)], XRCC4 rs1805377 GG [OR(95% CI) 2.07(1.10-3.90)] and rs1056503 TT [OR(95% CI) 2.17(1.16-4.07)], ERCC1 rs3212961 CC [OR(95% CI) 1.93(1.00-3.72)], RAD23B rs1805329 CC [OR(95% CI) 2.28(1.12-4.64)], and MGMT rs12917 CC, rs2308321 AA, and rs2308327 AA genotypes [OR(95% CI) 1.96(1.06-3.63), 2.02(1.09-3.75), and 2.23(1.16-4.29), respectively].	0.008001298	2014	XRCC4	5	83353158	T	A,G
rs1056503	25178586	7518	XRCC4	umls:C0024301	BeFree	The following genotypes in combination with hair dye use before 1980 were associated with FL risk: BRCA2 rs144848 AC+CC [odds ratio (OR) (95% confidence interval (CI)) 3.28(1.27-8.50)], WRN rs1346044 TT [OR(95% CI) 2.70(1.30-5.65)], XRCC3 rs861539 CT+TT [OR(95% CI) 2.76(1.32-5.77)], XRCC4 rs1805377 GG [OR(95% CI) 2.07(1.10-3.90)] and rs1056503 TT [OR(95% CI) 2.17(1.16-4.07)], ERCC1 rs3212961 CC [OR(95% CI) 1.93(1.00-3.72)], RAD23B rs1805329 CC [OR(95% CI) 2.28(1.12-4.64)], and MGMT rs12917 CC, rs2308321 AA, and rs2308327 AA genotypes [OR(95% CI) 1.96(1.06-3.63), 2.02(1.09-3.75), and 2.23(1.16-4.29), respectively].	0.002638474	2014	XRCC4	5	83353158	T	A,G
rs1056503	25178586	7486	WRN	umls:C0024301	BeFree	The following genotypes in combination with hair dye use before 1980 were associated with FL risk: BRCA2 rs144848 AC+CC [odds ratio (OR) (95% confidence interval (CI)) 3.28(1.27-8.50)], WRN rs1346044 TT [OR(95% CI) 2.70(1.30-5.65)], XRCC3 rs861539 CT+TT [OR(95% CI) 2.76(1.32-5.77)], XRCC4 rs1805377 GG [OR(95% CI) 2.07(1.10-3.90)] and rs1056503 TT [OR(95% CI) 2.17(1.16-4.07)], ERCC1 rs3212961 CC [OR(95% CI) 1.93(1.00-3.72)], RAD23B rs1805329 CC [OR(95% CI) 2.28(1.12-4.64)], and MGMT rs12917 CC, rs2308321 AA, and rs2308327 AA genotypes [OR(95% CI) 1.96(1.06-3.63), 2.02(1.09-3.75), and 2.23(1.16-4.29), respectively].	0.002909916	2014	XRCC4	5	83353158	T	A,G
rs1056503	25178586	675	BRCA2	umls:C0024301	BeFree	The following genotypes in combination with hair dye use before 1980 were associated with FL risk: BRCA2 rs144848 AC+CC [odds ratio (OR) (95% confidence interval (CI)) 3.28(1.27-8.50)], WRN rs1346044 TT [OR(95% CI) 2.70(1.30-5.65)], XRCC3 rs861539 CT+TT [OR(95% CI) 2.76(1.32-5.77)], XRCC4 rs1805377 GG [OR(95% CI) 2.07(1.10-3.90)] and rs1056503 TT [OR(95% CI) 2.17(1.16-4.07)], ERCC1 rs3212961 CC [OR(95% CI) 1.93(1.00-3.72)], RAD23B rs1805329 CC [OR(95% CI) 2.28(1.12-4.64)], and MGMT rs12917 CC, rs2308321 AA, and rs2308327 AA genotypes [OR(95% CI) 1.96(1.06-3.63), 2.02(1.09-3.75), and 2.23(1.16-4.29), respectively].	0.003181358	2014	XRCC4	5	83353158	T	A,G
rs1056503	25178586	4255	MGMT	umls:C0024301	BeFree	The following genotypes in combination with hair dye use before 1980 were associated with FL risk: BRCA2 rs144848 AC+CC [odds ratio (OR) (95% confidence interval (CI)) 3.28(1.27-8.50)], WRN rs1346044 TT [OR(95% CI) 2.70(1.30-5.65)], XRCC3 rs861539 CT+TT [OR(95% CI) 2.76(1.32-5.77)], XRCC4 rs1805377 GG [OR(95% CI) 2.07(1.10-3.90)] and rs1056503 TT [OR(95% CI) 2.17(1.16-4.07)], ERCC1 rs3212961 CC [OR(95% CI) 1.93(1.00-3.72)], RAD23B rs1805329 CC [OR(95% CI) 2.28(1.12-4.64)], and MGMT rs12917 CC, rs2308321 AA, and rs2308327 AA genotypes [OR(95% CI) 1.96(1.06-3.63), 2.02(1.09-3.75), and 2.23(1.16-4.29), respectively].	0.003181358	2014	XRCC4	5	83353158	T	A,G
rs1056503	25178586	2067	ERCC1	umls:C0024301	BeFree	The following genotypes in combination with hair dye use before 1980 were associated with FL risk: BRCA2 rs144848 AC+CC [odds ratio (OR) (95% confidence interval (CI)) 3.28(1.27-8.50)], WRN rs1346044 TT [OR(95% CI) 2.70(1.30-5.65)], XRCC3 rs861539 CT+TT [OR(95% CI) 2.76(1.32-5.77)], XRCC4 rs1805377 GG [OR(95% CI) 2.07(1.10-3.90)] and rs1056503 TT [OR(95% CI) 2.17(1.16-4.07)], ERCC1 rs3212961 CC [OR(95% CI) 1.93(1.00-3.72)], RAD23B rs1805329 CC [OR(95% CI) 2.28(1.12-4.64)], and MGMT rs12917 CC, rs2308321 AA, and rs2308327 AA genotypes [OR(95% CI) 1.96(1.06-3.63), 2.02(1.09-3.75), and 2.23(1.16-4.29), respectively].	0.002638474	2014	XRCC4	5	83353158	T	A,G
rs11082438	25279986	8170	SLC14A2	umls:C0024301	GWASCAT	Genome-wide association study identifies five susceptibility loci for follicular lymphoma outside the HLA region.	0.12	2014	SLC14A2	18	45285245	G	T
rs113488022	25511147	673	BRAF	umls:C0024301	BeFree	The performance of the BRAF V600E-specific VE1 antibody was compared with that of allele-specific polymerase chain reaction (PCR) in 22 formalin-fixed, paraffin-embedded (FFPE) specimens with HCL involvement, along with nine splenic marginal zone lymphomas (SMZLs), 10 follicular lymphomas (FLs), 10 mantle cell lymphomas (MCLs), and 10 chronic lymphocytic leukemia/small lymphocytic lymphomas (CLL/SLLs).	0.000271442	2015	BRAF	7	140753336	A	T,G,C
rs12711521	23055202	4155	MBP	umls:C0024301	BeFree	A SNP-based analysis showed that MBP rs8094402 was associated with decreased risks of overall NHL (allele risk OR = 0.72, P-trend = 0.0018), DLBCL (allele risk OR = 0.72, P-trend = 0.036), and FL (allele risk OR = 0.67, P-trend = 0.021), while MASP2 rs12711521 was associated with a decreased risk of DLBCL (allele risk OR = 0.57, P-trend = 0.0042).	0.000271442	2013	MASP2	1	11030859	C	A
rs12711521	23055202	10747	MASP2	umls:C0024301	BeFree	A SNP-based analysis showed that MBP rs8094402 was associated with decreased risks of overall NHL (allele risk OR = 0.72, P-trend = 0.0018), DLBCL (allele risk OR = 0.72, P-trend = 0.036), and FL (allele risk OR = 0.67, P-trend = 0.021), while MASP2 rs12711521 was associated with a decreased risk of DLBCL (allele risk OR = 0.57, P-trend = 0.0042).	0.000271442	2013	MASP2	1	11030859	C	A
rs12917	25178586	7517	XRCC3	umls:C0024301	BeFree	The following genotypes in combination with hair dye use before 1980 were associated with FL risk: BRCA2 rs144848 AC+CC [odds ratio (OR) (95% confidence interval (CI)) 3.28(1.27-8.50)], WRN rs1346044 TT [OR(95% CI) 2.70(1.30-5.65)], XRCC3 rs861539 CT+TT [OR(95% CI) 2.76(1.32-5.77)], XRCC4 rs1805377 GG [OR(95% CI) 2.07(1.10-3.90)] and rs1056503 TT [OR(95% CI) 2.17(1.16-4.07)], ERCC1 rs3212961 CC [OR(95% CI) 1.93(1.00-3.72)], RAD23B rs1805329 CC [OR(95% CI) 2.28(1.12-4.64)], and MGMT rs12917 CC, rs2308321 AA, and rs2308327 AA genotypes [OR(95% CI) 1.96(1.06-3.63), 2.02(1.09-3.75), and 2.23(1.16-4.29), respectively].	0.008001298	2014	MGMT	10	129708019	C	T
rs12917	25178586	7518	XRCC4	umls:C0024301	BeFree	The following genotypes in combination with hair dye use before 1980 were associated with FL risk: BRCA2 rs144848 AC+CC [odds ratio (OR) (95% confidence interval (CI)) 3.28(1.27-8.50)], WRN rs1346044 TT [OR(95% CI) 2.70(1.30-5.65)], XRCC3 rs861539 CT+TT [OR(95% CI) 2.76(1.32-5.77)], XRCC4 rs1805377 GG [OR(95% CI) 2.07(1.10-3.90)] and rs1056503 TT [OR(95% CI) 2.17(1.16-4.07)], ERCC1 rs3212961 CC [OR(95% CI) 1.93(1.00-3.72)], RAD23B rs1805329 CC [OR(95% CI) 2.28(1.12-4.64)], and MGMT rs12917 CC, rs2308321 AA, and rs2308327 AA genotypes [OR(95% CI) 1.96(1.06-3.63), 2.02(1.09-3.75), and 2.23(1.16-4.29), respectively].	0.002638474	2014	MGMT	10	129708019	C	T
rs12917	25178586	675	BRCA2	umls:C0024301	BeFree	The following genotypes in combination with hair dye use before 1980 were associated with FL risk: BRCA2 rs144848 AC+CC [odds ratio (OR) (95% confidence interval (CI)) 3.28(1.27-8.50)], WRN rs1346044 TT [OR(95% CI) 2.70(1.30-5.65)], XRCC3 rs861539 CT+TT [OR(95% CI) 2.76(1.32-5.77)], XRCC4 rs1805377 GG [OR(95% CI) 2.07(1.10-3.90)] and rs1056503 TT [OR(95% CI) 2.17(1.16-4.07)], ERCC1 rs3212961 CC [OR(95% CI) 1.93(1.00-3.72)], RAD23B rs1805329 CC [OR(95% CI) 2.28(1.12-4.64)], and MGMT rs12917 CC, rs2308321 AA, and rs2308327 AA genotypes [OR(95% CI) 1.96(1.06-3.63), 2.02(1.09-3.75), and 2.23(1.16-4.29), respectively].	0.003181358	2014	MGMT	10	129708019	C	T
rs12917	25178586	2067	ERCC1	umls:C0024301	BeFree	The following genotypes in combination with hair dye use before 1980 were associated with FL risk: BRCA2 rs144848 AC+CC [odds ratio (OR) (95% confidence interval (CI)) 3.28(1.27-8.50)], WRN rs1346044 TT [OR(95% CI) 2.70(1.30-5.65)], XRCC3 rs861539 CT+TT [OR(95% CI) 2.76(1.32-5.77)], XRCC4 rs1805377 GG [OR(95% CI) 2.07(1.10-3.90)] and rs1056503 TT [OR(95% CI) 2.17(1.16-4.07)], ERCC1 rs3212961 CC [OR(95% CI) 1.93(1.00-3.72)], RAD23B rs1805329 CC [OR(95% CI) 2.28(1.12-4.64)], and MGMT rs12917 CC, rs2308321 AA, and rs2308327 AA genotypes [OR(95% CI) 1.96(1.06-3.63), 2.02(1.09-3.75), and 2.23(1.16-4.29), respectively].	0.002638474	2014	MGMT	10	129708019	C	T
rs12917	22430443	4255	MGMT	umls:C0024301	BeFree	After stratification by major NHL histological subtypes, MGMT (rs12917) modified the association between chlorinated solvents and the risk of diffuse large B-cell lymphoma (Pfor interaction=0.0027) and follicular lymphoma (Pfor interaction=0.0024).	0.003181358	2012	MGMT	10	129708019	C	T
rs12917	25178586	7486	WRN	umls:C0024301	BeFree	The following genotypes in combination with hair dye use before 1980 were associated with FL risk: BRCA2 rs144848 AC+CC [odds ratio (OR) (95% confidence interval (CI)) 3.28(1.27-8.50)], WRN rs1346044 TT [OR(95% CI) 2.70(1.30-5.65)], XRCC3 rs861539 CT+TT [OR(95% CI) 2.76(1.32-5.77)], XRCC4 rs1805377 GG [OR(95% CI) 2.07(1.10-3.90)] and rs1056503 TT [OR(95% CI) 2.17(1.16-4.07)], ERCC1 rs3212961 CC [OR(95% CI) 1.93(1.00-3.72)], RAD23B rs1805329 CC [OR(95% CI) 2.28(1.12-4.64)], and MGMT rs12917 CC, rs2308321 AA, and rs2308327 AA genotypes [OR(95% CI) 1.96(1.06-3.63), 2.02(1.09-3.75), and 2.23(1.16-4.29), respectively].	0.002909916	2014	MGMT	10	129708019	C	T
rs12917	25178586	5887	RAD23B	umls:C0024301	BeFree	The following genotypes in combination with hair dye use before 1980 were associated with FL risk: BRCA2 rs144848 AC+CC [odds ratio (OR) (95% confidence interval (CI)) 3.28(1.27-8.50)], WRN rs1346044 TT [OR(95% CI) 2.70(1.30-5.65)], XRCC3 rs861539 CT+TT [OR(95% CI) 2.76(1.32-5.77)], XRCC4 rs1805377 GG [OR(95% CI) 2.07(1.10-3.90)] and rs1056503 TT [OR(95% CI) 2.17(1.16-4.07)], ERCC1 rs3212961 CC [OR(95% CI) 1.93(1.00-3.72)], RAD23B rs1805329 CC [OR(95% CI) 2.28(1.12-4.64)], and MGMT rs12917 CC, rs2308321 AA, and rs2308327 AA genotypes [OR(95% CI) 1.96(1.06-3.63), 2.02(1.09-3.75), and 2.23(1.16-4.29), respectively].	0.002638474	2014	MGMT	10	129708019	C	T
rs12917	25178586	4255	MGMT	umls:C0024301	BeFree	The following genotypes in combination with hair dye use before 1980 were associated with FL risk: BRCA2 rs144848 AC+CC [odds ratio (OR) (95% confidence interval (CI)) 3.28(1.27-8.50)], WRN rs1346044 TT [OR(95% CI) 2.70(1.30-5.65)], XRCC3 rs861539 CT+TT [OR(95% CI) 2.76(1.32-5.77)], XRCC4 rs1805377 GG [OR(95% CI) 2.07(1.10-3.90)] and rs1056503 TT [OR(95% CI) 2.17(1.16-4.07)], ERCC1 rs3212961 CC [OR(95% CI) 1.93(1.00-3.72)], RAD23B rs1805329 CC [OR(95% CI) 2.28(1.12-4.64)], and MGMT rs12917 CC, rs2308321 AA, and rs2308327 AA genotypes [OR(95% CI) 1.96(1.06-3.63), 2.02(1.09-3.75), and 2.23(1.16-4.29), respectively].	0.003181358	2014	MGMT	10	129708019	C	T
rs13254990	25279986	596	BCL2	umls:C0024301	BeFree	Five non-HLA loci were associated with FL risk: 11q23.3 (rs4938573, p = 5.79 × 10(-20)) near CXCR5; 11q24.3 (rs4937362, p = 6.76 × 10(-11)) near ETS1; 3q28 (rs6444305, p = 1.10 × 10(-10)) in LPP; 18q21.33 (rs17749561, p = 8.28 × 10(-10)) near BCL2; and 8q24.21 (rs13254990, p = 1.06 × 10(-8)) near PVT1.	0.343804516	2014	PVT1	8	128064205	C	T
rs13254990	25279986	4026	LPP	umls:C0024301	BeFree	Five non-HLA loci were associated with FL risk: 11q23.3 (rs4938573, p = 5.79 × 10(-20)) near CXCR5; 11q24.3 (rs4937362, p = 6.76 × 10(-11)) near ETS1; 3q28 (rs6444305, p = 1.10 × 10(-10)) in LPP; 18q21.33 (rs17749561, p = 8.28 × 10(-10)) near BCL2; and 8q24.21 (rs13254990, p = 1.06 × 10(-8)) near PVT1.	0.120271442	2014	PVT1	8	128064205	C	T
rs13254990	25279986	5820	PVT1	umls:C0024301	BeFree	Five non-HLA loci were associated with FL risk: 11q23.3 (rs4938573, p = 5.79 × 10(-20)) near CXCR5; 11q24.3 (rs4937362, p = 6.76 × 10(-11)) near ETS1; 3q28 (rs6444305, p = 1.10 × 10(-10)) in LPP; 18q21.33 (rs17749561, p = 8.28 × 10(-10)) near BCL2; and 8q24.21 (rs13254990, p = 1.06 × 10(-8)) near PVT1.	0.120271442	2014	PVT1	8	128064205	C	T
rs13254990	25279986	5820	PVT1	umls:C0024301	GWASCAT	Five non-HLA loci were associated with FL risk: 11q23.3 (rs4938573, p = 5.79 × 10(-20)) near CXCR5; 11q24.3 (rs4937362, p = 6.76 × 10(-11)) near ETS1; 3q28 (rs6444305, p = 1.10 × 10(-10)) in LPP; 18q21.33 (rs17749561, p = 8.28 × 10(-10)) near BCL2; and 8q24.21 (rs13254990, p = 1.06 × 10(-8)) near PVT1.	0.120271442	2014	PVT1	8	128064205	C	T
rs13254990	25279986	2113	ETS1	umls:C0024301	BeFree	Five non-HLA loci were associated with FL risk: 11q23.3 (rs4938573, p = 5.79 × 10(-20)) near CXCR5; 11q24.3 (rs4937362, p = 6.76 × 10(-11)) near ETS1; 3q28 (rs6444305, p = 1.10 × 10(-10)) in LPP; 18q21.33 (rs17749561, p = 8.28 × 10(-10)) near BCL2; and 8q24.21 (rs13254990, p = 1.06 × 10(-8)) near PVT1.	0.000271442	2014	PVT1	8	128064205	C	T
rs13254990	25279986	643	CXCR5	umls:C0024301	BeFree	Five non-HLA loci were associated with FL risk: 11q23.3 (rs4938573, p = 5.79 × 10(-20)) near CXCR5; 11q24.3 (rs4937362, p = 6.76 × 10(-11)) near ETS1; 3q28 (rs6444305, p = 1.10 × 10(-10)) in LPP; 18q21.33 (rs17749561, p = 8.28 × 10(-10)) near BCL2; and 8q24.21 (rs13254990, p = 1.06 × 10(-8)) near PVT1.	0.000814326	2014	PVT1	8	128064205	C	T
rs1346044	25178586	7486	WRN	umls:C0024301	BeFree	The following genotypes in combination with hair dye use before 1980 were associated with FL risk: BRCA2 rs144848 AC+CC [odds ratio (OR) (95% confidence interval (CI)) 3.28(1.27-8.50)], WRN rs1346044 TT [OR(95% CI) 2.70(1.30-5.65)], XRCC3 rs861539 CT+TT [OR(95% CI) 2.76(1.32-5.77)], XRCC4 rs1805377 GG [OR(95% CI) 2.07(1.10-3.90)] and rs1056503 TT [OR(95% CI) 2.17(1.16-4.07)], ERCC1 rs3212961 CC [OR(95% CI) 1.93(1.00-3.72)], RAD23B rs1805329 CC [OR(95% CI) 2.28(1.12-4.64)], and MGMT rs12917 CC, rs2308321 AA, and rs2308327 AA genotypes [OR(95% CI) 1.96(1.06-3.63), 2.02(1.09-3.75), and 2.23(1.16-4.29), respectively].	0.002909916	2014	WRN;LOC105379359	8	31167138	T	C
rs1346044	25178586	2067	ERCC1	umls:C0024301	BeFree	The following genotypes in combination with hair dye use before 1980 were associated with FL risk: BRCA2 rs144848 AC+CC [odds ratio (OR) (95% confidence interval (CI)) 3.28(1.27-8.50)], WRN rs1346044 TT [OR(95% CI) 2.70(1.30-5.65)], XRCC3 rs861539 CT+TT [OR(95% CI) 2.76(1.32-5.77)], XRCC4 rs1805377 GG [OR(95% CI) 2.07(1.10-3.90)] and rs1056503 TT [OR(95% CI) 2.17(1.16-4.07)], ERCC1 rs3212961 CC [OR(95% CI) 1.93(1.00-3.72)], RAD23B rs1805329 CC [OR(95% CI) 2.28(1.12-4.64)], and MGMT rs12917 CC, rs2308321 AA, and rs2308327 AA genotypes [OR(95% CI) 1.96(1.06-3.63), 2.02(1.09-3.75), and 2.23(1.16-4.29), respectively].	0.002638474	2014	WRN;LOC105379359	8	31167138	T	C
rs1346044	25178586	675	BRCA2	umls:C0024301	BeFree	The following genotypes in combination with hair dye use before 1980 were associated with FL risk: BRCA2 rs144848 AC+CC [odds ratio (OR) (95% confidence interval (CI)) 3.28(1.27-8.50)], WRN rs1346044 TT [OR(95% CI) 2.70(1.30-5.65)], XRCC3 rs861539 CT+TT [OR(95% CI) 2.76(1.32-5.77)], XRCC4 rs1805377 GG [OR(95% CI) 2.07(1.10-3.90)] and rs1056503 TT [OR(95% CI) 2.17(1.16-4.07)], ERCC1 rs3212961 CC [OR(95% CI) 1.93(1.00-3.72)], RAD23B rs1805329 CC [OR(95% CI) 2.28(1.12-4.64)], and MGMT rs12917 CC, rs2308321 AA, and rs2308327 AA genotypes [OR(95% CI) 1.96(1.06-3.63), 2.02(1.09-3.75), and 2.23(1.16-4.29), respectively].	0.003181358	2014	WRN;LOC105379359	8	31167138	T	C
rs1346044	25178586	7517	XRCC3	umls:C0024301	BeFree	The following genotypes in combination with hair dye use before 1980 were associated with FL risk: BRCA2 rs144848 AC+CC [odds ratio (OR) (95% confidence interval (CI)) 3.28(1.27-8.50)], WRN rs1346044 TT [OR(95% CI) 2.70(1.30-5.65)], XRCC3 rs861539 CT+TT [OR(95% CI) 2.76(1.32-5.77)], XRCC4 rs1805377 GG [OR(95% CI) 2.07(1.10-3.90)] and rs1056503 TT [OR(95% CI) 2.17(1.16-4.07)], ERCC1 rs3212961 CC [OR(95% CI) 1.93(1.00-3.72)], RAD23B rs1805329 CC [OR(95% CI) 2.28(1.12-4.64)], and MGMT rs12917 CC, rs2308321 AA, and rs2308327 AA genotypes [OR(95% CI) 1.96(1.06-3.63), 2.02(1.09-3.75), and 2.23(1.16-4.29), respectively].	0.008001298	2014	WRN;LOC105379359	8	31167138	T	C
rs1346044	25178586	4255	MGMT	umls:C0024301	BeFree	The following genotypes in combination with hair dye use before 1980 were associated with FL risk: BRCA2 rs144848 AC+CC [odds ratio (OR) (95% confidence interval (CI)) 3.28(1.27-8.50)], WRN rs1346044 TT [OR(95% CI) 2.70(1.30-5.65)], XRCC3 rs861539 CT+TT [OR(95% CI) 2.76(1.32-5.77)], XRCC4 rs1805377 GG [OR(95% CI) 2.07(1.10-3.90)] and rs1056503 TT [OR(95% CI) 2.17(1.16-4.07)], ERCC1 rs3212961 CC [OR(95% CI) 1.93(1.00-3.72)], RAD23B rs1805329 CC [OR(95% CI) 2.28(1.12-4.64)], and MGMT rs12917 CC, rs2308321 AA, and rs2308327 AA genotypes [OR(95% CI) 1.96(1.06-3.63), 2.02(1.09-3.75), and 2.23(1.16-4.29), respectively].	0.003181358	2014	WRN;LOC105379359	8	31167138	T	C
rs1346044	25178586	5887	RAD23B	umls:C0024301	BeFree	The following genotypes in combination with hair dye use before 1980 were associated with FL risk: BRCA2 rs144848 AC+CC [odds ratio (OR) (95% confidence interval (CI)) 3.28(1.27-8.50)], WRN rs1346044 TT [OR(95% CI) 2.70(1.30-5.65)], XRCC3 rs861539 CT+TT [OR(95% CI) 2.76(1.32-5.77)], XRCC4 rs1805377 GG [OR(95% CI) 2.07(1.10-3.90)] and rs1056503 TT [OR(95% CI) 2.17(1.16-4.07)], ERCC1 rs3212961 CC [OR(95% CI) 1.93(1.00-3.72)], RAD23B rs1805329 CC [OR(95% CI) 2.28(1.12-4.64)], and MGMT rs12917 CC, rs2308321 AA, and rs2308327 AA genotypes [OR(95% CI) 1.96(1.06-3.63), 2.02(1.09-3.75), and 2.23(1.16-4.29), respectively].	0.002638474	2014	WRN;LOC105379359	8	31167138	T	C
rs1346044	25178586	7518	XRCC4	umls:C0024301	BeFree	The following genotypes in combination with hair dye use before 1980 were associated with FL risk: BRCA2 rs144848 AC+CC [odds ratio (OR) (95% confidence interval (CI)) 3.28(1.27-8.50)], WRN rs1346044 TT [OR(95% CI) 2.70(1.30-5.65)], XRCC3 rs861539 CT+TT [OR(95% CI) 2.76(1.32-5.77)], XRCC4 rs1805377 GG [OR(95% CI) 2.07(1.10-3.90)] and rs1056503 TT [OR(95% CI) 2.17(1.16-4.07)], ERCC1 rs3212961 CC [OR(95% CI) 1.93(1.00-3.72)], RAD23B rs1805329 CC [OR(95% CI) 2.28(1.12-4.64)], and MGMT rs12917 CC, rs2308321 AA, and rs2308327 AA genotypes [OR(95% CI) 1.96(1.06-3.63), 2.02(1.09-3.75), and 2.23(1.16-4.29), respectively].	0.002638474	2014	WRN;LOC105379359	8	31167138	T	C
rs144848	25178586	675	BRCA2	umls:C0024301	BeFree	The following genotypes in combination with hair dye use before 1980 were associated with FL risk: BRCA2 rs144848 AC+CC [odds ratio (OR) (95% confidence interval (CI)) 3.28(1.27-8.50)], WRN rs1346044 TT [OR(95% CI) 2.70(1.30-5.65)], XRCC3 rs861539 CT+TT [OR(95% CI) 2.76(1.32-5.77)], XRCC4 rs1805377 GG [OR(95% CI) 2.07(1.10-3.90)] and rs1056503 TT [OR(95% CI) 2.17(1.16-4.07)], ERCC1 rs3212961 CC [OR(95% CI) 1.93(1.00-3.72)], RAD23B rs1805329 CC [OR(95% CI) 2.28(1.12-4.64)], and MGMT rs12917 CC, rs2308321 AA, and rs2308327 AA genotypes [OR(95% CI) 1.96(1.06-3.63), 2.02(1.09-3.75), and 2.23(1.16-4.29), respectively].	0.003181358	2014	BRCA2	13	32332592	A	C
rs144848	21476145	675	BRCA2	umls:C0024301	BeFree	Association of follicular lymphoma risk with BRCA2 N372H polymorphism in Slovak population.	0.003181358	2012	BRCA2	13	32332592	A	C
rs144848	21476145	3981	LIG4	umls:C0024301	BeFree	We have genotyped polymorphisms in the RAG1 (K820R), LIG4 (T9I), BRCA2 (N372H), and WRN (V114I) genes in 108 patients with histologically proven FL diagnosis and 127 healthy controls.	0.002638474	2012	BRCA2	13	32332592	A	C
rs144848	25178586	7518	XRCC4	umls:C0024301	BeFree	The following genotypes in combination with hair dye use before 1980 were associated with FL risk: BRCA2 rs144848 AC+CC [odds ratio (OR) (95% confidence interval (CI)) 3.28(1.27-8.50)], WRN rs1346044 TT [OR(95% CI) 2.70(1.30-5.65)], XRCC3 rs861539 CT+TT [OR(95% CI) 2.76(1.32-5.77)], XRCC4 rs1805377 GG [OR(95% CI) 2.07(1.10-3.90)] and rs1056503 TT [OR(95% CI) 2.17(1.16-4.07)], ERCC1 rs3212961 CC [OR(95% CI) 1.93(1.00-3.72)], RAD23B rs1805329 CC [OR(95% CI) 2.28(1.12-4.64)], and MGMT rs12917 CC, rs2308321 AA, and rs2308327 AA genotypes [OR(95% CI) 1.96(1.06-3.63), 2.02(1.09-3.75), and 2.23(1.16-4.29), respectively].	0.002638474	2014	BRCA2	13	32332592	A	C
rs144848	21476145	5896	RAG1	umls:C0024301	BeFree	We have genotyped polymorphisms in the RAG1 (K820R), LIG4 (T9I), BRCA2 (N372H), and WRN (V114I) genes in 108 patients with histologically proven FL diagnosis and 127 healthy controls.	0.002638474	2012	BRCA2	13	32332592	A	C
rs144848	25178586	2067	ERCC1	umls:C0024301	BeFree	The following genotypes in combination with hair dye use before 1980 were associated with FL risk: BRCA2 rs144848 AC+CC [odds ratio (OR) (95% confidence interval (CI)) 3.28(1.27-8.50)], WRN rs1346044 TT [OR(95% CI) 2.70(1.30-5.65)], XRCC3 rs861539 CT+TT [OR(95% CI) 2.76(1.32-5.77)], XRCC4 rs1805377 GG [OR(95% CI) 2.07(1.10-3.90)] and rs1056503 TT [OR(95% CI) 2.17(1.16-4.07)], ERCC1 rs3212961 CC [OR(95% CI) 1.93(1.00-3.72)], RAD23B rs1805329 CC [OR(95% CI) 2.28(1.12-4.64)], and MGMT rs12917 CC, rs2308321 AA, and rs2308327 AA genotypes [OR(95% CI) 1.96(1.06-3.63), 2.02(1.09-3.75), and 2.23(1.16-4.29), respectively].	0.002638474	2014	BRCA2	13	32332592	A	C
rs144848	25178586	7486	WRN	umls:C0024301	BeFree	The following genotypes in combination with hair dye use before 1980 were associated with FL risk: BRCA2 rs144848 AC+CC [odds ratio (OR) (95% confidence interval (CI)) 3.28(1.27-8.50)], WRN rs1346044 TT [OR(95% CI) 2.70(1.30-5.65)], XRCC3 rs861539 CT+TT [OR(95% CI) 2.76(1.32-5.77)], XRCC4 rs1805377 GG [OR(95% CI) 2.07(1.10-3.90)] and rs1056503 TT [OR(95% CI) 2.17(1.16-4.07)], ERCC1 rs3212961 CC [OR(95% CI) 1.93(1.00-3.72)], RAD23B rs1805329 CC [OR(95% CI) 2.28(1.12-4.64)], and MGMT rs12917 CC, rs2308321 AA, and rs2308327 AA genotypes [OR(95% CI) 1.96(1.06-3.63), 2.02(1.09-3.75), and 2.23(1.16-4.29), respectively].	0.002909916	2014	BRCA2	13	32332592	A	C
rs144848	25178586	5887	RAD23B	umls:C0024301	BeFree	The following genotypes in combination with hair dye use before 1980 were associated with FL risk: BRCA2 rs144848 AC+CC [odds ratio (OR) (95% confidence interval (CI)) 3.28(1.27-8.50)], WRN rs1346044 TT [OR(95% CI) 2.70(1.30-5.65)], XRCC3 rs861539 CT+TT [OR(95% CI) 2.76(1.32-5.77)], XRCC4 rs1805377 GG [OR(95% CI) 2.07(1.10-3.90)] and rs1056503 TT [OR(95% CI) 2.17(1.16-4.07)], ERCC1 rs3212961 CC [OR(95% CI) 1.93(1.00-3.72)], RAD23B rs1805329 CC [OR(95% CI) 2.28(1.12-4.64)], and MGMT rs12917 CC, rs2308321 AA, and rs2308327 AA genotypes [OR(95% CI) 1.96(1.06-3.63), 2.02(1.09-3.75), and 2.23(1.16-4.29), respectively].	0.002638474	2014	BRCA2	13	32332592	A	C
rs144848	21476145	7486	WRN	umls:C0024301	BeFree	We have genotyped polymorphisms in the RAG1 (K820R), LIG4 (T9I), BRCA2 (N372H), and WRN (V114I) genes in 108 patients with histologically proven FL diagnosis and 127 healthy controls.	0.002909916	2012	BRCA2	13	32332592	A	C
rs144848	25178586	4255	MGMT	umls:C0024301	BeFree	The following genotypes in combination with hair dye use before 1980 were associated with FL risk: BRCA2 rs144848 AC+CC [odds ratio (OR) (95% confidence interval (CI)) 3.28(1.27-8.50)], WRN rs1346044 TT [OR(95% CI) 2.70(1.30-5.65)], XRCC3 rs861539 CT+TT [OR(95% CI) 2.76(1.32-5.77)], XRCC4 rs1805377 GG [OR(95% CI) 2.07(1.10-3.90)] and rs1056503 TT [OR(95% CI) 2.17(1.16-4.07)], ERCC1 rs3212961 CC [OR(95% CI) 1.93(1.00-3.72)], RAD23B rs1805329 CC [OR(95% CI) 2.28(1.12-4.64)], and MGMT rs12917 CC, rs2308321 AA, and rs2308327 AA genotypes [OR(95% CI) 1.96(1.06-3.63), 2.02(1.09-3.75), and 2.23(1.16-4.29), respectively].	0.003181358	2014	BRCA2	13	32332592	A	C
rs144848	25178586	7517	XRCC3	umls:C0024301	BeFree	The following genotypes in combination with hair dye use before 1980 were associated with FL risk: BRCA2 rs144848 AC+CC [odds ratio (OR) (95% confidence interval (CI)) 3.28(1.27-8.50)], WRN rs1346044 TT [OR(95% CI) 2.70(1.30-5.65)], XRCC3 rs861539 CT+TT [OR(95% CI) 2.76(1.32-5.77)], XRCC4 rs1805377 GG [OR(95% CI) 2.07(1.10-3.90)] and rs1056503 TT [OR(95% CI) 2.17(1.16-4.07)], ERCC1 rs3212961 CC [OR(95% CI) 1.93(1.00-3.72)], RAD23B rs1805329 CC [OR(95% CI) 2.28(1.12-4.64)], and MGMT rs12917 CC, rs2308321 AA, and rs2308327 AA genotypes [OR(95% CI) 1.96(1.06-3.63), 2.02(1.09-3.75), and 2.23(1.16-4.29), respectively].	0.008001298	2014	BRCA2	13	32332592	A	C
rs1494555	20952689	7124	TNF	umls:C0024301	BeFree	After stratification by common B-cell lymphoma subtypes, a significant interaction was observed for IFNGR2 (rs9808753 P(forinteraction) = .006), IL13 (rs20541 P(forinteraction) = .019), and IL7R (rs1494555 P(forinteraction) = .012) for marginal zone B-cell lymphoma; IL7R (rs1494555 P(forinteraction) = .017) for small lymphocytic lymphoma/chronic lymphocytic leukemia; and IL12A (rs568408 P(forinteraction) = .013) and TNF (1799724 P(forinteraction) = .04) for follicular lymphoma.	0.006905599	2011	IL7R	5	35871088	G	A
rs1695	17454600	2950	GSTP1	umls:C0024301	BeFree	We studied deletions of GSTM1 and GSTT1, and the GSTP1 Ile(105)Val polymorphism in 89 patients with follicular lymphoma (FL).	0.005276948	2007	GSTP1	11	67585218	A	G
rs17749561	25279986	5820	PVT1	umls:C0024301	BeFree	Five non-HLA loci were associated with FL risk: 11q23.3 (rs4938573, p = 5.79 × 10(-20)) near CXCR5; 11q24.3 (rs4937362, p = 6.76 × 10(-11)) near ETS1; 3q28 (rs6444305, p = 1.10 × 10(-10)) in LPP; 18q21.33 (rs17749561, p = 8.28 × 10(-10)) near BCL2; and 8q24.21 (rs13254990, p = 1.06 × 10(-8)) near PVT1.	0.120271442	2014	NA	18	63115978	G	A
rs17749561	25279986	643	CXCR5	umls:C0024301	BeFree	Five non-HLA loci were associated with FL risk: 11q23.3 (rs4938573, p = 5.79 × 10(-20)) near CXCR5; 11q24.3 (rs4937362, p = 6.76 × 10(-11)) near ETS1; 3q28 (rs6444305, p = 1.10 × 10(-10)) in LPP; 18q21.33 (rs17749561, p = 8.28 × 10(-10)) near BCL2; and 8q24.21 (rs13254990, p = 1.06 × 10(-8)) near PVT1.	0.000814326	2014	NA	18	63115978	G	A
rs17749561	25279986	596	BCL2	umls:C0024301	BeFree	Five non-HLA loci were associated with FL risk: 11q23.3 (rs4938573, p = 5.79 × 10(-20)) near CXCR5; 11q24.3 (rs4937362, p = 6.76 × 10(-11)) near ETS1; 3q28 (rs6444305, p = 1.10 × 10(-10)) in LPP; 18q21.33 (rs17749561, p = 8.28 × 10(-10)) near BCL2; and 8q24.21 (rs13254990, p = 1.06 × 10(-8)) near PVT1.	0.343804516	2014	NA	18	63115978	G	A
rs17749561	25279986	2113	ETS1	umls:C0024301	BeFree	Five non-HLA loci were associated with FL risk: 11q23.3 (rs4938573, p = 5.79 × 10(-20)) near CXCR5; 11q24.3 (rs4937362, p = 6.76 × 10(-11)) near ETS1; 3q28 (rs6444305, p = 1.10 × 10(-10)) in LPP; 18q21.33 (rs17749561, p = 8.28 × 10(-10)) near BCL2; and 8q24.21 (rs13254990, p = 1.06 × 10(-8)) near PVT1.	0.000271442	2014	NA	18	63115978	G	A
rs17749561	25279986	4026	LPP	umls:C0024301	BeFree	Five non-HLA loci were associated with FL risk: 11q23.3 (rs4938573, p = 5.79 × 10(-20)) near CXCR5; 11q24.3 (rs4937362, p = 6.76 × 10(-11)) near ETS1; 3q28 (rs6444305, p = 1.10 × 10(-10)) in LPP; 18q21.33 (rs17749561, p = 8.28 × 10(-10)) near BCL2; and 8q24.21 (rs13254990, p = 1.06 × 10(-8)) near PVT1.	0.120271442	2014	NA	18	63115978	G	A
rs1805329	25178586	4255	MGMT	umls:C0024301	BeFree	The following genotypes in combination with hair dye use before 1980 were associated with FL risk: BRCA2 rs144848 AC+CC [odds ratio (OR) (95% confidence interval (CI)) 3.28(1.27-8.50)], WRN rs1346044 TT [OR(95% CI) 2.70(1.30-5.65)], XRCC3 rs861539 CT+TT [OR(95% CI) 2.76(1.32-5.77)], XRCC4 rs1805377 GG [OR(95% CI) 2.07(1.10-3.90)] and rs1056503 TT [OR(95% CI) 2.17(1.16-4.07)], ERCC1 rs3212961 CC [OR(95% CI) 1.93(1.00-3.72)], RAD23B rs1805329 CC [OR(95% CI) 2.28(1.12-4.64)], and MGMT rs12917 CC, rs2308321 AA, and rs2308327 AA genotypes [OR(95% CI) 1.96(1.06-3.63), 2.02(1.09-3.75), and 2.23(1.16-4.29), respectively].	0.003181358	2014	RAD23B	9	107322047	C	T
rs1805329	25178586	5887	RAD23B	umls:C0024301	BeFree	The following genotypes in combination with hair dye use before 1980 were associated with FL risk: BRCA2 rs144848 AC+CC [odds ratio (OR) (95% confidence interval (CI)) 3.28(1.27-8.50)], WRN rs1346044 TT [OR(95% CI) 2.70(1.30-5.65)], XRCC3 rs861539 CT+TT [OR(95% CI) 2.76(1.32-5.77)], XRCC4 rs1805377 GG [OR(95% CI) 2.07(1.10-3.90)] and rs1056503 TT [OR(95% CI) 2.17(1.16-4.07)], ERCC1 rs3212961 CC [OR(95% CI) 1.93(1.00-3.72)], RAD23B rs1805329 CC [OR(95% CI) 2.28(1.12-4.64)], and MGMT rs12917 CC, rs2308321 AA, and rs2308327 AA genotypes [OR(95% CI) 1.96(1.06-3.63), 2.02(1.09-3.75), and 2.23(1.16-4.29), respectively].	0.002638474	2014	RAD23B	9	107322047	C	T
rs1805329	25178586	7486	WRN	umls:C0024301	BeFree	The following genotypes in combination with hair dye use before 1980 were associated with FL risk: BRCA2 rs144848 AC+CC [odds ratio (OR) (95% confidence interval (CI)) 3.28(1.27-8.50)], WRN rs1346044 TT [OR(95% CI) 2.70(1.30-5.65)], XRCC3 rs861539 CT+TT [OR(95% CI) 2.76(1.32-5.77)], XRCC4 rs1805377 GG [OR(95% CI) 2.07(1.10-3.90)] and rs1056503 TT [OR(95% CI) 2.17(1.16-4.07)], ERCC1 rs3212961 CC [OR(95% CI) 1.93(1.00-3.72)], RAD23B rs1805329 CC [OR(95% CI) 2.28(1.12-4.64)], and MGMT rs12917 CC, rs2308321 AA, and rs2308327 AA genotypes [OR(95% CI) 1.96(1.06-3.63), 2.02(1.09-3.75), and 2.23(1.16-4.29), respectively].	0.002909916	2014	RAD23B	9	107322047	C	T
rs1805329	25178586	7517	XRCC3	umls:C0024301	BeFree	The following genotypes in combination with hair dye use before 1980 were associated with FL risk: BRCA2 rs144848 AC+CC [odds ratio (OR) (95% confidence interval (CI)) 3.28(1.27-8.50)], WRN rs1346044 TT [OR(95% CI) 2.70(1.30-5.65)], XRCC3 rs861539 CT+TT [OR(95% CI) 2.76(1.32-5.77)], XRCC4 rs1805377 GG [OR(95% CI) 2.07(1.10-3.90)] and rs1056503 TT [OR(95% CI) 2.17(1.16-4.07)], ERCC1 rs3212961 CC [OR(95% CI) 1.93(1.00-3.72)], RAD23B rs1805329 CC [OR(95% CI) 2.28(1.12-4.64)], and MGMT rs12917 CC, rs2308321 AA, and rs2308327 AA genotypes [OR(95% CI) 1.96(1.06-3.63), 2.02(1.09-3.75), and 2.23(1.16-4.29), respectively].	0.008001298	2014	RAD23B	9	107322047	C	T
rs1805329	25178586	675	BRCA2	umls:C0024301	BeFree	The following genotypes in combination with hair dye use before 1980 were associated with FL risk: BRCA2 rs144848 AC+CC [odds ratio (OR) (95% confidence interval (CI)) 3.28(1.27-8.50)], WRN rs1346044 TT [OR(95% CI) 2.70(1.30-5.65)], XRCC3 rs861539 CT+TT [OR(95% CI) 2.76(1.32-5.77)], XRCC4 rs1805377 GG [OR(95% CI) 2.07(1.10-3.90)] and rs1056503 TT [OR(95% CI) 2.17(1.16-4.07)], ERCC1 rs3212961 CC [OR(95% CI) 1.93(1.00-3.72)], RAD23B rs1805329 CC [OR(95% CI) 2.28(1.12-4.64)], and MGMT rs12917 CC, rs2308321 AA, and rs2308327 AA genotypes [OR(95% CI) 1.96(1.06-3.63), 2.02(1.09-3.75), and 2.23(1.16-4.29), respectively].	0.003181358	2014	RAD23B	9	107322047	C	T
rs1805329	25178586	2067	ERCC1	umls:C0024301	BeFree	The following genotypes in combination with hair dye use before 1980 were associated with FL risk: BRCA2 rs144848 AC+CC [odds ratio (OR) (95% confidence interval (CI)) 3.28(1.27-8.50)], WRN rs1346044 TT [OR(95% CI) 2.70(1.30-5.65)], XRCC3 rs861539 CT+TT [OR(95% CI) 2.76(1.32-5.77)], XRCC4 rs1805377 GG [OR(95% CI) 2.07(1.10-3.90)] and rs1056503 TT [OR(95% CI) 2.17(1.16-4.07)], ERCC1 rs3212961 CC [OR(95% CI) 1.93(1.00-3.72)], RAD23B rs1805329 CC [OR(95% CI) 2.28(1.12-4.64)], and MGMT rs12917 CC, rs2308321 AA, and rs2308327 AA genotypes [OR(95% CI) 1.96(1.06-3.63), 2.02(1.09-3.75), and 2.23(1.16-4.29), respectively].	0.002638474	2014	RAD23B	9	107322047	C	T
rs1805329	25178586	7518	XRCC4	umls:C0024301	BeFree	The following genotypes in combination with hair dye use before 1980 were associated with FL risk: BRCA2 rs144848 AC+CC [odds ratio (OR) (95% confidence interval (CI)) 3.28(1.27-8.50)], WRN rs1346044 TT [OR(95% CI) 2.70(1.30-5.65)], XRCC3 rs861539 CT+TT [OR(95% CI) 2.76(1.32-5.77)], XRCC4 rs1805377 GG [OR(95% CI) 2.07(1.10-3.90)] and rs1056503 TT [OR(95% CI) 2.17(1.16-4.07)], ERCC1 rs3212961 CC [OR(95% CI) 1.93(1.00-3.72)], RAD23B rs1805329 CC [OR(95% CI) 2.28(1.12-4.64)], and MGMT rs12917 CC, rs2308321 AA, and rs2308327 AA genotypes [OR(95% CI) 1.96(1.06-3.63), 2.02(1.09-3.75), and 2.23(1.16-4.29), respectively].	0.002638474	2014	RAD23B	9	107322047	C	T
rs1805377	25178586	675	BRCA2	umls:C0024301	BeFree	The following genotypes in combination with hair dye use before 1980 were associated with FL risk: BRCA2 rs144848 AC+CC [odds ratio (OR) (95% confidence interval (CI)) 3.28(1.27-8.50)], WRN rs1346044 TT [OR(95% CI) 2.70(1.30-5.65)], XRCC3 rs861539 CT+TT [OR(95% CI) 2.76(1.32-5.77)], XRCC4 rs1805377 GG [OR(95% CI) 2.07(1.10-3.90)] and rs1056503 TT [OR(95% CI) 2.17(1.16-4.07)], ERCC1 rs3212961 CC [OR(95% CI) 1.93(1.00-3.72)], RAD23B rs1805329 CC [OR(95% CI) 2.28(1.12-4.64)], and MGMT rs12917 CC, rs2308321 AA, and rs2308327 AA genotypes [OR(95% CI) 1.96(1.06-3.63), 2.02(1.09-3.75), and 2.23(1.16-4.29), respectively].	0.003181358	2014	XRCC4	5	83353124	G	A
rs1805377	25178586	7518	XRCC4	umls:C0024301	BeFree	The following genotypes in combination with hair dye use before 1980 were associated with FL risk: BRCA2 rs144848 AC+CC [odds ratio (OR) (95% confidence interval (CI)) 3.28(1.27-8.50)], WRN rs1346044 TT [OR(95% CI) 2.70(1.30-5.65)], XRCC3 rs861539 CT+TT [OR(95% CI) 2.76(1.32-5.77)], XRCC4 rs1805377 GG [OR(95% CI) 2.07(1.10-3.90)] and rs1056503 TT [OR(95% CI) 2.17(1.16-4.07)], ERCC1 rs3212961 CC [OR(95% CI) 1.93(1.00-3.72)], RAD23B rs1805329 CC [OR(95% CI) 2.28(1.12-4.64)], and MGMT rs12917 CC, rs2308321 AA, and rs2308327 AA genotypes [OR(95% CI) 1.96(1.06-3.63), 2.02(1.09-3.75), and 2.23(1.16-4.29), respectively].	0.002638474	2014	XRCC4	5	83353124	G	A
rs1805377	25178586	4255	MGMT	umls:C0024301	BeFree	The following genotypes in combination with hair dye use before 1980 were associated with FL risk: BRCA2 rs144848 AC+CC [odds ratio (OR) (95% confidence interval (CI)) 3.28(1.27-8.50)], WRN rs1346044 TT [OR(95% CI) 2.70(1.30-5.65)], XRCC3 rs861539 CT+TT [OR(95% CI) 2.76(1.32-5.77)], XRCC4 rs1805377 GG [OR(95% CI) 2.07(1.10-3.90)] and rs1056503 TT [OR(95% CI) 2.17(1.16-4.07)], ERCC1 rs3212961 CC [OR(95% CI) 1.93(1.00-3.72)], RAD23B rs1805329 CC [OR(95% CI) 2.28(1.12-4.64)], and MGMT rs12917 CC, rs2308321 AA, and rs2308327 AA genotypes [OR(95% CI) 1.96(1.06-3.63), 2.02(1.09-3.75), and 2.23(1.16-4.29), respectively].	0.003181358	2014	XRCC4	5	83353124	G	A
rs1805377	25178586	5887	RAD23B	umls:C0024301	BeFree	The following genotypes in combination with hair dye use before 1980 were associated with FL risk: BRCA2 rs144848 AC+CC [odds ratio (OR) (95% confidence interval (CI)) 3.28(1.27-8.50)], WRN rs1346044 TT [OR(95% CI) 2.70(1.30-5.65)], XRCC3 rs861539 CT+TT [OR(95% CI) 2.76(1.32-5.77)], XRCC4 rs1805377 GG [OR(95% CI) 2.07(1.10-3.90)] and rs1056503 TT [OR(95% CI) 2.17(1.16-4.07)], ERCC1 rs3212961 CC [OR(95% CI) 1.93(1.00-3.72)], RAD23B rs1805329 CC [OR(95% CI) 2.28(1.12-4.64)], and MGMT rs12917 CC, rs2308321 AA, and rs2308327 AA genotypes [OR(95% CI) 1.96(1.06-3.63), 2.02(1.09-3.75), and 2.23(1.16-4.29), respectively].	0.002638474	2014	XRCC4	5	83353124	G	A
rs1805377	25178586	7486	WRN	umls:C0024301	BeFree	The following genotypes in combination with hair dye use before 1980 were associated with FL risk: BRCA2 rs144848 AC+CC [odds ratio (OR) (95% confidence interval (CI)) 3.28(1.27-8.50)], WRN rs1346044 TT [OR(95% CI) 2.70(1.30-5.65)], XRCC3 rs861539 CT+TT [OR(95% CI) 2.76(1.32-5.77)], XRCC4 rs1805377 GG [OR(95% CI) 2.07(1.10-3.90)] and rs1056503 TT [OR(95% CI) 2.17(1.16-4.07)], ERCC1 rs3212961 CC [OR(95% CI) 1.93(1.00-3.72)], RAD23B rs1805329 CC [OR(95% CI) 2.28(1.12-4.64)], and MGMT rs12917 CC, rs2308321 AA, and rs2308327 AA genotypes [OR(95% CI) 1.96(1.06-3.63), 2.02(1.09-3.75), and 2.23(1.16-4.29), respectively].	0.002909916	2014	XRCC4	5	83353124	G	A
rs1805377	25178586	7517	XRCC3	umls:C0024301	BeFree	The following genotypes in combination with hair dye use before 1980 were associated with FL risk: BRCA2 rs144848 AC+CC [odds ratio (OR) (95% confidence interval (CI)) 3.28(1.27-8.50)], WRN rs1346044 TT [OR(95% CI) 2.70(1.30-5.65)], XRCC3 rs861539 CT+TT [OR(95% CI) 2.76(1.32-5.77)], XRCC4 rs1805377 GG [OR(95% CI) 2.07(1.10-3.90)] and rs1056503 TT [OR(95% CI) 2.17(1.16-4.07)], ERCC1 rs3212961 CC [OR(95% CI) 1.93(1.00-3.72)], RAD23B rs1805329 CC [OR(95% CI) 2.28(1.12-4.64)], and MGMT rs12917 CC, rs2308321 AA, and rs2308327 AA genotypes [OR(95% CI) 1.96(1.06-3.63), 2.02(1.09-3.75), and 2.23(1.16-4.29), respectively].	0.008001298	2014	XRCC4	5	83353124	G	A
rs1805377	25178586	2067	ERCC1	umls:C0024301	BeFree	The following genotypes in combination with hair dye use before 1980 were associated with FL risk: BRCA2 rs144848 AC+CC [odds ratio (OR) (95% confidence interval (CI)) 3.28(1.27-8.50)], WRN rs1346044 TT [OR(95% CI) 2.70(1.30-5.65)], XRCC3 rs861539 CT+TT [OR(95% CI) 2.76(1.32-5.77)], XRCC4 rs1805377 GG [OR(95% CI) 2.07(1.10-3.90)] and rs1056503 TT [OR(95% CI) 2.17(1.16-4.07)], ERCC1 rs3212961 CC [OR(95% CI) 1.93(1.00-3.72)], RAD23B rs1805329 CC [OR(95% CI) 2.28(1.12-4.64)], and MGMT rs12917 CC, rs2308321 AA, and rs2308327 AA genotypes [OR(95% CI) 1.96(1.06-3.63), 2.02(1.09-3.75), and 2.23(1.16-4.29), respectively].	0.002638474	2014	XRCC4	5	83353124	G	A
rs1883832	20473910	958	CD40	umls:C0024301	BeFree	Data from earlier studies that are part of this pooling study implicate a functional polymorphism (-1C>T, rs1883832) in the TNFRSF5 gene encoding CD40 in the etiology of follicular lymphoma.	0.0089015	2011	CD40	20	46118343	T	C
rs20541	20952689	7124	TNF	umls:C0024301	BeFree	After stratification by common B-cell lymphoma subtypes, a significant interaction was observed for IFNGR2 (rs9808753 P(forinteraction) = .006), IL13 (rs20541 P(forinteraction) = .019), and IL7R (rs1494555 P(forinteraction) = .012) for marginal zone B-cell lymphoma; IL7R (rs1494555 P(forinteraction) = .017) for small lymphocytic lymphoma/chronic lymphocytic leukemia; and IL12A (rs568408 P(forinteraction) = .013) and TNF (1799724 P(forinteraction) = .04) for follicular lymphoma.	0.006905599	2011	IL13	5	132660272	A	G
rs2227973	21476145	7486	WRN	umls:C0024301	BeFree	We have genotyped polymorphisms in the RAG1 (K820R), LIG4 (T9I), BRCA2 (N372H), and WRN (V114I) genes in 108 patients with histologically proven FL diagnosis and 127 healthy controls.	0.002909916	2012	RAG1	11	36575763	A	G
rs2227973	21476145	3981	LIG4	umls:C0024301	BeFree	We have genotyped polymorphisms in the RAG1 (K820R), LIG4 (T9I), BRCA2 (N372H), and WRN (V114I) genes in 108 patients with histologically proven FL diagnosis and 127 healthy controls.	0.002638474	2012	RAG1	11	36575763	A	G
rs2227973	21476145	5896	RAG1	umls:C0024301	BeFree	We have genotyped polymorphisms in the RAG1 (K820R), LIG4 (T9I), BRCA2 (N372H), and WRN (V114I) genes in 108 patients with histologically proven FL diagnosis and 127 healthy controls.	0.002638474	2012	RAG1	11	36575763	A	G
rs2230009	21476145	3981	LIG4	umls:C0024301	BeFree	We have genotyped polymorphisms in the RAG1 (K820R), LIG4 (T9I), BRCA2 (N372H), and WRN (V114I) genes in 108 patients with histologically proven FL diagnosis and 127 healthy controls.	0.002638474	2012	WRN	8	31064419	G	A
rs2230009	21476145	7486	WRN	umls:C0024301	BeFree	We have genotyped polymorphisms in the RAG1 (K820R), LIG4 (T9I), BRCA2 (N372H), and WRN (V114I) genes in 108 patients with histologically proven FL diagnosis and 127 healthy controls.	0.002909916	2012	WRN	8	31064419	G	A
rs2230009	21476145	5896	RAG1	umls:C0024301	BeFree	We have genotyped polymorphisms in the RAG1 (K820R), LIG4 (T9I), BRCA2 (N372H), and WRN (V114I) genes in 108 patients with histologically proven FL diagnosis and 127 healthy controls.	0.002638474	2012	WRN	8	31064419	G	A
rs2308321	25178586	7486	WRN	umls:C0024301	BeFree	The following genotypes in combination with hair dye use before 1980 were associated with FL risk: BRCA2 rs144848 AC+CC [odds ratio (OR) (95% confidence interval (CI)) 3.28(1.27-8.50)], WRN rs1346044 TT [OR(95% CI) 2.70(1.30-5.65)], XRCC3 rs861539 CT+TT [OR(95% CI) 2.76(1.32-5.77)], XRCC4 rs1805377 GG [OR(95% CI) 2.07(1.10-3.90)] and rs1056503 TT [OR(95% CI) 2.17(1.16-4.07)], ERCC1 rs3212961 CC [OR(95% CI) 1.93(1.00-3.72)], RAD23B rs1805329 CC [OR(95% CI) 2.28(1.12-4.64)], and MGMT rs12917 CC, rs2308321 AA, and rs2308327 AA genotypes [OR(95% CI) 1.96(1.06-3.63), 2.02(1.09-3.75), and 2.23(1.16-4.29), respectively].	0.002909916	2014	MGMT;LOC105378559	10	129766800	A	G
rs2308321	25178586	2067	ERCC1	umls:C0024301	BeFree	The following genotypes in combination with hair dye use before 1980 were associated with FL risk: BRCA2 rs144848 AC+CC [odds ratio (OR) (95% confidence interval (CI)) 3.28(1.27-8.50)], WRN rs1346044 TT [OR(95% CI) 2.70(1.30-5.65)], XRCC3 rs861539 CT+TT [OR(95% CI) 2.76(1.32-5.77)], XRCC4 rs1805377 GG [OR(95% CI) 2.07(1.10-3.90)] and rs1056503 TT [OR(95% CI) 2.17(1.16-4.07)], ERCC1 rs3212961 CC [OR(95% CI) 1.93(1.00-3.72)], RAD23B rs1805329 CC [OR(95% CI) 2.28(1.12-4.64)], and MGMT rs12917 CC, rs2308321 AA, and rs2308327 AA genotypes [OR(95% CI) 1.96(1.06-3.63), 2.02(1.09-3.75), and 2.23(1.16-4.29), respectively].	0.002638474	2014	MGMT;LOC105378559	10	129766800	A	G
rs2308321	25178586	7518	XRCC4	umls:C0024301	BeFree	The following genotypes in combination with hair dye use before 1980 were associated with FL risk: BRCA2 rs144848 AC+CC [odds ratio (OR) (95% confidence interval (CI)) 3.28(1.27-8.50)], WRN rs1346044 TT [OR(95% CI) 2.70(1.30-5.65)], XRCC3 rs861539 CT+TT [OR(95% CI) 2.76(1.32-5.77)], XRCC4 rs1805377 GG [OR(95% CI) 2.07(1.10-3.90)] and rs1056503 TT [OR(95% CI) 2.17(1.16-4.07)], ERCC1 rs3212961 CC [OR(95% CI) 1.93(1.00-3.72)], RAD23B rs1805329 CC [OR(95% CI) 2.28(1.12-4.64)], and MGMT rs12917 CC, rs2308321 AA, and rs2308327 AA genotypes [OR(95% CI) 1.96(1.06-3.63), 2.02(1.09-3.75), and 2.23(1.16-4.29), respectively].	0.002638474	2014	MGMT;LOC105378559	10	129766800	A	G
rs2308321	25178586	4255	MGMT	umls:C0024301	BeFree	The following genotypes in combination with hair dye use before 1980 were associated with FL risk: BRCA2 rs144848 AC+CC [odds ratio (OR) (95% confidence interval (CI)) 3.28(1.27-8.50)], WRN rs1346044 TT [OR(95% CI) 2.70(1.30-5.65)], XRCC3 rs861539 CT+TT [OR(95% CI) 2.76(1.32-5.77)], XRCC4 rs1805377 GG [OR(95% CI) 2.07(1.10-3.90)] and rs1056503 TT [OR(95% CI) 2.17(1.16-4.07)], ERCC1 rs3212961 CC [OR(95% CI) 1.93(1.00-3.72)], RAD23B rs1805329 CC [OR(95% CI) 2.28(1.12-4.64)], and MGMT rs12917 CC, rs2308321 AA, and rs2308327 AA genotypes [OR(95% CI) 1.96(1.06-3.63), 2.02(1.09-3.75), and 2.23(1.16-4.29), respectively].	0.003181358	2014	MGMT;LOC105378559	10	129766800	A	G
rs2308321	25178586	5887	RAD23B	umls:C0024301	BeFree	The following genotypes in combination with hair dye use before 1980 were associated with FL risk: BRCA2 rs144848 AC+CC [odds ratio (OR) (95% confidence interval (CI)) 3.28(1.27-8.50)], WRN rs1346044 TT [OR(95% CI) 2.70(1.30-5.65)], XRCC3 rs861539 CT+TT [OR(95% CI) 2.76(1.32-5.77)], XRCC4 rs1805377 GG [OR(95% CI) 2.07(1.10-3.90)] and rs1056503 TT [OR(95% CI) 2.17(1.16-4.07)], ERCC1 rs3212961 CC [OR(95% CI) 1.93(1.00-3.72)], RAD23B rs1805329 CC [OR(95% CI) 2.28(1.12-4.64)], and MGMT rs12917 CC, rs2308321 AA, and rs2308327 AA genotypes [OR(95% CI) 1.96(1.06-3.63), 2.02(1.09-3.75), and 2.23(1.16-4.29), respectively].	0.002638474	2014	MGMT;LOC105378559	10	129766800	A	G
rs2308321	25178586	675	BRCA2	umls:C0024301	BeFree	The following genotypes in combination with hair dye use before 1980 were associated with FL risk: BRCA2 rs144848 AC+CC [odds ratio (OR) (95% confidence interval (CI)) 3.28(1.27-8.50)], WRN rs1346044 TT [OR(95% CI) 2.70(1.30-5.65)], XRCC3 rs861539 CT+TT [OR(95% CI) 2.76(1.32-5.77)], XRCC4 rs1805377 GG [OR(95% CI) 2.07(1.10-3.90)] and rs1056503 TT [OR(95% CI) 2.17(1.16-4.07)], ERCC1 rs3212961 CC [OR(95% CI) 1.93(1.00-3.72)], RAD23B rs1805329 CC [OR(95% CI) 2.28(1.12-4.64)], and MGMT rs12917 CC, rs2308321 AA, and rs2308327 AA genotypes [OR(95% CI) 1.96(1.06-3.63), 2.02(1.09-3.75), and 2.23(1.16-4.29), respectively].	0.003181358	2014	MGMT;LOC105378559	10	129766800	A	G
rs2308321	25178586	7517	XRCC3	umls:C0024301	BeFree	The following genotypes in combination with hair dye use before 1980 were associated with FL risk: BRCA2 rs144848 AC+CC [odds ratio (OR) (95% confidence interval (CI)) 3.28(1.27-8.50)], WRN rs1346044 TT [OR(95% CI) 2.70(1.30-5.65)], XRCC3 rs861539 CT+TT [OR(95% CI) 2.76(1.32-5.77)], XRCC4 rs1805377 GG [OR(95% CI) 2.07(1.10-3.90)] and rs1056503 TT [OR(95% CI) 2.17(1.16-4.07)], ERCC1 rs3212961 CC [OR(95% CI) 1.93(1.00-3.72)], RAD23B rs1805329 CC [OR(95% CI) 2.28(1.12-4.64)], and MGMT rs12917 CC, rs2308321 AA, and rs2308327 AA genotypes [OR(95% CI) 1.96(1.06-3.63), 2.02(1.09-3.75), and 2.23(1.16-4.29), respectively].	0.008001298	2014	MGMT;LOC105378559	10	129766800	A	G
rs2308327	25178586	5887	RAD23B	umls:C0024301	BeFree	The following genotypes in combination with hair dye use before 1980 were associated with FL risk: BRCA2 rs144848 AC+CC [odds ratio (OR) (95% confidence interval (CI)) 3.28(1.27-8.50)], WRN rs1346044 TT [OR(95% CI) 2.70(1.30-5.65)], XRCC3 rs861539 CT+TT [OR(95% CI) 2.76(1.32-5.77)], XRCC4 rs1805377 GG [OR(95% CI) 2.07(1.10-3.90)] and rs1056503 TT [OR(95% CI) 2.17(1.16-4.07)], ERCC1 rs3212961 CC [OR(95% CI) 1.93(1.00-3.72)], RAD23B rs1805329 CC [OR(95% CI) 2.28(1.12-4.64)], and MGMT rs12917 CC, rs2308321 AA, and rs2308327 AA genotypes [OR(95% CI) 1.96(1.06-3.63), 2.02(1.09-3.75), and 2.23(1.16-4.29), respectively].	0.002638474	2014	MGMT;LOC105378559	10	129766906	A	G
rs2308327	25178586	7486	WRN	umls:C0024301	BeFree	The following genotypes in combination with hair dye use before 1980 were associated with FL risk: BRCA2 rs144848 AC+CC [odds ratio (OR) (95% confidence interval (CI)) 3.28(1.27-8.50)], WRN rs1346044 TT [OR(95% CI) 2.70(1.30-5.65)], XRCC3 rs861539 CT+TT [OR(95% CI) 2.76(1.32-5.77)], XRCC4 rs1805377 GG [OR(95% CI) 2.07(1.10-3.90)] and rs1056503 TT [OR(95% CI) 2.17(1.16-4.07)], ERCC1 rs3212961 CC [OR(95% CI) 1.93(1.00-3.72)], RAD23B rs1805329 CC [OR(95% CI) 2.28(1.12-4.64)], and MGMT rs12917 CC, rs2308321 AA, and rs2308327 AA genotypes [OR(95% CI) 1.96(1.06-3.63), 2.02(1.09-3.75), and 2.23(1.16-4.29), respectively].	0.002909916	2014	MGMT;LOC105378559	10	129766906	A	G
rs2308327	25178586	7518	XRCC4	umls:C0024301	BeFree	The following genotypes in combination with hair dye use before 1980 were associated with FL risk: BRCA2 rs144848 AC+CC [odds ratio (OR) (95% confidence interval (CI)) 3.28(1.27-8.50)], WRN rs1346044 TT [OR(95% CI) 2.70(1.30-5.65)], XRCC3 rs861539 CT+TT [OR(95% CI) 2.76(1.32-5.77)], XRCC4 rs1805377 GG [OR(95% CI) 2.07(1.10-3.90)] and rs1056503 TT [OR(95% CI) 2.17(1.16-4.07)], ERCC1 rs3212961 CC [OR(95% CI) 1.93(1.00-3.72)], RAD23B rs1805329 CC [OR(95% CI) 2.28(1.12-4.64)], and MGMT rs12917 CC, rs2308321 AA, and rs2308327 AA genotypes [OR(95% CI) 1.96(1.06-3.63), 2.02(1.09-3.75), and 2.23(1.16-4.29), respectively].	0.002638474	2014	MGMT;LOC105378559	10	129766906	A	G
rs2308327	25178586	4255	MGMT	umls:C0024301	BeFree	The following genotypes in combination with hair dye use before 1980 were associated with FL risk: BRCA2 rs144848 AC+CC [odds ratio (OR) (95% confidence interval (CI)) 3.28(1.27-8.50)], WRN rs1346044 TT [OR(95% CI) 2.70(1.30-5.65)], XRCC3 rs861539 CT+TT [OR(95% CI) 2.76(1.32-5.77)], XRCC4 rs1805377 GG [OR(95% CI) 2.07(1.10-3.90)] and rs1056503 TT [OR(95% CI) 2.17(1.16-4.07)], ERCC1 rs3212961 CC [OR(95% CI) 1.93(1.00-3.72)], RAD23B rs1805329 CC [OR(95% CI) 2.28(1.12-4.64)], and MGMT rs12917 CC, rs2308321 AA, and rs2308327 AA genotypes [OR(95% CI) 1.96(1.06-3.63), 2.02(1.09-3.75), and 2.23(1.16-4.29), respectively].	0.003181358	2014	MGMT;LOC105378559	10	129766906	A	G
rs2308327	25178586	7517	XRCC3	umls:C0024301	BeFree	The following genotypes in combination with hair dye use before 1980 were associated with FL risk: BRCA2 rs144848 AC+CC [odds ratio (OR) (95% confidence interval (CI)) 3.28(1.27-8.50)], WRN rs1346044 TT [OR(95% CI) 2.70(1.30-5.65)], XRCC3 rs861539 CT+TT [OR(95% CI) 2.76(1.32-5.77)], XRCC4 rs1805377 GG [OR(95% CI) 2.07(1.10-3.90)] and rs1056503 TT [OR(95% CI) 2.17(1.16-4.07)], ERCC1 rs3212961 CC [OR(95% CI) 1.93(1.00-3.72)], RAD23B rs1805329 CC [OR(95% CI) 2.28(1.12-4.64)], and MGMT rs12917 CC, rs2308321 AA, and rs2308327 AA genotypes [OR(95% CI) 1.96(1.06-3.63), 2.02(1.09-3.75), and 2.23(1.16-4.29), respectively].	0.008001298	2014	MGMT;LOC105378559	10	129766906	A	G
rs2308327	25178586	2067	ERCC1	umls:C0024301	BeFree	The following genotypes in combination with hair dye use before 1980 were associated with FL risk: BRCA2 rs144848 AC+CC [odds ratio (OR) (95% confidence interval (CI)) 3.28(1.27-8.50)], WRN rs1346044 TT [OR(95% CI) 2.70(1.30-5.65)], XRCC3 rs861539 CT+TT [OR(95% CI) 2.76(1.32-5.77)], XRCC4 rs1805377 GG [OR(95% CI) 2.07(1.10-3.90)] and rs1056503 TT [OR(95% CI) 2.17(1.16-4.07)], ERCC1 rs3212961 CC [OR(95% CI) 1.93(1.00-3.72)], RAD23B rs1805329 CC [OR(95% CI) 2.28(1.12-4.64)], and MGMT rs12917 CC, rs2308321 AA, and rs2308327 AA genotypes [OR(95% CI) 1.96(1.06-3.63), 2.02(1.09-3.75), and 2.23(1.16-4.29), respectively].	0.002638474	2014	MGMT;LOC105378559	10	129766906	A	G
rs2308327	25178586	675	BRCA2	umls:C0024301	BeFree	The following genotypes in combination with hair dye use before 1980 were associated with FL risk: BRCA2 rs144848 AC+CC [odds ratio (OR) (95% confidence interval (CI)) 3.28(1.27-8.50)], WRN rs1346044 TT [OR(95% CI) 2.70(1.30-5.65)], XRCC3 rs861539 CT+TT [OR(95% CI) 2.76(1.32-5.77)], XRCC4 rs1805377 GG [OR(95% CI) 2.07(1.10-3.90)] and rs1056503 TT [OR(95% CI) 2.17(1.16-4.07)], ERCC1 rs3212961 CC [OR(95% CI) 1.93(1.00-3.72)], RAD23B rs1805329 CC [OR(95% CI) 2.28(1.12-4.64)], and MGMT rs12917 CC, rs2308321 AA, and rs2308327 AA genotypes [OR(95% CI) 1.96(1.06-3.63), 2.02(1.09-3.75), and 2.23(1.16-4.29), respectively].	0.003181358	2014	MGMT;LOC105378559	10	129766906	A	G
rs2647012	23025665	3126	HLA-DRB4	umls:C0024301	BeFree	In recent genome-wide association studies (GWAS) of FL, several genetic susceptibility loci have been identified on chromosome 6p21.33 (rs6457327) and 6p21.32 (rs10484561, rs2647012) in the human leukocyte antigen class I and class II regions.	0.001085767	2012	NA	6	32696681	T	C
rs2647012	24304973	129831	RBM45	umls:C0024301	BeFree	We confirmed that FL-protective rs2647012-linked variants, in high linkage disequilibrium with the extended haplotype DRB115:01-DQA101:02-DQB1*06:02, correlate with increased HLA-DQB1 expression.	0.000814326	2013	NA	6	32696681	T	C
rs2647012	22296171	129831	RBM45	umls:C0024301	BeFree	Moreover, DRB115-DQA101-DQB1*06 was highly correlated with an established FL risk locus, rs2647012.	0.000814326	2012	NA	6	32696681	T	C
rs2647012	22911334	266629	SEC14L3	umls:C0024301	BeFree	The TAP2 SNP was strongly associated with follicular lymphoma (FL, OR = 1.82, 95%CI 1.46-2.26; p = 6.9 × 10(-8)), and was independent of other known loci (rs10484561 and rs2647012) from this region.	0.000271442	2012	NA	6	32696681	T	C
rs2647012	21533074	3119	HLA-DQB1	umls:C0024301	GAD	[GWAS of follicular lymphoma reveals allelic heterogeneity at 6p21.32 and suggests shared genetic susceptibility with diffuse large B-cell lymphoma.]	0.005276948	2011	NA	6	32696681	T	C
rs2681416	25279986	942	CD86	umls:C0024301	GWASCAT	Genome-wide association study identifies five susceptibility loci for follicular lymphoma outside the HLA region.	0.12	2014	CD86	3	122098766	G	A
rs2855429	21148756	6015	RING1	umls:C0024301	BeFree	Accordingly, SNPs in RING1/RXRB (rs2855429), AIF1 (rs2857597), and BAT4 (rs3115667) were associated with NHL (P-trends ≤ 0.0002) and both diffuse large B-cell and follicular lymphomas (P-trends < 0.05).	0.000271442	2011	COL11A2	6	33190412	A	C
rs2855429	21148756	6257	RXRB	umls:C0024301	BeFree	Accordingly, SNPs in RING1/RXRB (rs2855429), AIF1 (rs2857597), and BAT4 (rs3115667) were associated with NHL (P-trends ≤ 0.0002) and both diffuse large B-cell and follicular lymphomas (P-trends < 0.05).	0.000271442	2011	COL11A2	6	33190412	A	C
rs2855429	21148756	199	AIF1	umls:C0024301	BeFree	Accordingly, SNPs in RING1/RXRB (rs2855429), AIF1 (rs2857597), and BAT4 (rs3115667) were associated with NHL (P-trends ≤ 0.0002) and both diffuse large B-cell and follicular lymphomas (P-trends < 0.05).	0.000271442	2011	COL11A2	6	33190412	A	C
rs2855429	21148756	7918	GPANK1	umls:C0024301	BeFree	Accordingly, SNPs in RING1/RXRB (rs2855429), AIF1 (rs2857597), and BAT4 (rs3115667) were associated with NHL (P-trends ≤ 0.0002) and both diffuse large B-cell and follicular lymphomas (P-trends < 0.05).	0.000271442	2011	COL11A2	6	33190412	A	C
rs2857597	21148756	199	AIF1	umls:C0024301	BeFree	Accordingly, SNPs in RING1/RXRB (rs2855429), AIF1 (rs2857597), and BAT4 (rs3115667) were associated with NHL (P-trends ≤ 0.0002) and both diffuse large B-cell and follicular lymphomas (P-trends < 0.05).	0.000271442	2011	AIF1	6	31617223	T	A
rs2857597	21148756	6257	RXRB	umls:C0024301	BeFree	Accordingly, SNPs in RING1/RXRB (rs2855429), AIF1 (rs2857597), and BAT4 (rs3115667) were associated with NHL (P-trends ≤ 0.0002) and both diffuse large B-cell and follicular lymphomas (P-trends < 0.05).	0.000271442	2011	AIF1	6	31617223	T	A
rs2857597	21148756	6015	RING1	umls:C0024301	BeFree	Accordingly, SNPs in RING1/RXRB (rs2855429), AIF1 (rs2857597), and BAT4 (rs3115667) were associated with NHL (P-trends ≤ 0.0002) and both diffuse large B-cell and follicular lymphomas (P-trends < 0.05).	0.000271442	2011	AIF1	6	31617223	T	A
rs2857597	21148756	7918	GPANK1	umls:C0024301	BeFree	Accordingly, SNPs in RING1/RXRB (rs2855429), AIF1 (rs2857597), and BAT4 (rs3115667) were associated with NHL (P-trends ≤ 0.0002) and both diffuse large B-cell and follicular lymphomas (P-trends < 0.05).	0.000271442	2011	AIF1	6	31617223	T	A
rs3020314	18636124	2099	ESR1	umls:C0024301	BeFree	Four ESR1 SNPs were associated with follicular lymphoma (FL) in the U.S. study, with rs3020314 remaining associated with reduced risk of FL after multiple testing adjustments [odds ratio (OR) = 0.42, 95% confidence interval (CI) = 0.23-0.77) and replication in the German study (OR = 0.24, 95% CI = 0.06-0.94).	0.000271442	2008	ESR1	6	151949537	C	T
rs3115667	21148756	6257	RXRB	umls:C0024301	BeFree	Accordingly, SNPs in RING1/RXRB (rs2855429), AIF1 (rs2857597), and BAT4 (rs3115667) were associated with NHL (P-trends ≤ 0.0002) and both diffuse large B-cell and follicular lymphomas (P-trends < 0.05).	0.000271442	2011	NA	6	31675622	T	C
rs3115667	21148756	199	AIF1	umls:C0024301	BeFree	Accordingly, SNPs in RING1/RXRB (rs2855429), AIF1 (rs2857597), and BAT4 (rs3115667) were associated with NHL (P-trends ≤ 0.0002) and both diffuse large B-cell and follicular lymphomas (P-trends < 0.05).	0.000271442	2011	NA	6	31675622	T	C
rs3115667	21148756	7918	GPANK1	umls:C0024301	BeFree	Accordingly, SNPs in RING1/RXRB (rs2855429), AIF1 (rs2857597), and BAT4 (rs3115667) were associated with NHL (P-trends ≤ 0.0002) and both diffuse large B-cell and follicular lymphomas (P-trends < 0.05).	0.000271442	2011	NA	6	31675622	T	C
rs3115667	21148756	6015	RING1	umls:C0024301	BeFree	Accordingly, SNPs in RING1/RXRB (rs2855429), AIF1 (rs2857597), and BAT4 (rs3115667) were associated with NHL (P-trends ≤ 0.0002) and both diffuse large B-cell and follicular lymphomas (P-trends < 0.05).	0.000271442	2011	NA	6	31675622	T	C
rs3212961	25178586	7517	XRCC3	umls:C0024301	BeFree	The following genotypes in combination with hair dye use before 1980 were associated with FL risk: BRCA2 rs144848 AC+CC [odds ratio (OR) (95% confidence interval (CI)) 3.28(1.27-8.50)], WRN rs1346044 TT [OR(95% CI) 2.70(1.30-5.65)], XRCC3 rs861539 CT+TT [OR(95% CI) 2.76(1.32-5.77)], XRCC4 rs1805377 GG [OR(95% CI) 2.07(1.10-3.90)] and rs1056503 TT [OR(95% CI) 2.17(1.16-4.07)], ERCC1 rs3212961 CC [OR(95% CI) 1.93(1.00-3.72)], RAD23B rs1805329 CC [OR(95% CI) 2.28(1.12-4.64)], and MGMT rs12917 CC, rs2308321 AA, and rs2308327 AA genotypes [OR(95% CI) 1.96(1.06-3.63), 2.02(1.09-3.75), and 2.23(1.16-4.29), respectively].	0.008001298	2014	ERCC1	19	45419065	G	T,A
rs3212961	25178586	2067	ERCC1	umls:C0024301	BeFree	The following genotypes in combination with hair dye use before 1980 were associated with FL risk: BRCA2 rs144848 AC+CC [odds ratio (OR) (95% confidence interval (CI)) 3.28(1.27-8.50)], WRN rs1346044 TT [OR(95% CI) 2.70(1.30-5.65)], XRCC3 rs861539 CT+TT [OR(95% CI) 2.76(1.32-5.77)], XRCC4 rs1805377 GG [OR(95% CI) 2.07(1.10-3.90)] and rs1056503 TT [OR(95% CI) 2.17(1.16-4.07)], ERCC1 rs3212961 CC [OR(95% CI) 1.93(1.00-3.72)], RAD23B rs1805329 CC [OR(95% CI) 2.28(1.12-4.64)], and MGMT rs12917 CC, rs2308321 AA, and rs2308327 AA genotypes [OR(95% CI) 1.96(1.06-3.63), 2.02(1.09-3.75), and 2.23(1.16-4.29), respectively].	0.002638474	2014	ERCC1	19	45419065	G	T,A
rs3212961	25178586	7486	WRN	umls:C0024301	BeFree	The following genotypes in combination with hair dye use before 1980 were associated with FL risk: BRCA2 rs144848 AC+CC [odds ratio (OR) (95% confidence interval (CI)) 3.28(1.27-8.50)], WRN rs1346044 TT [OR(95% CI) 2.70(1.30-5.65)], XRCC3 rs861539 CT+TT [OR(95% CI) 2.76(1.32-5.77)], XRCC4 rs1805377 GG [OR(95% CI) 2.07(1.10-3.90)] and rs1056503 TT [OR(95% CI) 2.17(1.16-4.07)], ERCC1 rs3212961 CC [OR(95% CI) 1.93(1.00-3.72)], RAD23B rs1805329 CC [OR(95% CI) 2.28(1.12-4.64)], and MGMT rs12917 CC, rs2308321 AA, and rs2308327 AA genotypes [OR(95% CI) 1.96(1.06-3.63), 2.02(1.09-3.75), and 2.23(1.16-4.29), respectively].	0.002909916	2014	ERCC1	19	45419065	G	T,A
rs3212961	25178586	5887	RAD23B	umls:C0024301	BeFree	The following genotypes in combination with hair dye use before 1980 were associated with FL risk: BRCA2 rs144848 AC+CC [odds ratio (OR) (95% confidence interval (CI)) 3.28(1.27-8.50)], WRN rs1346044 TT [OR(95% CI) 2.70(1.30-5.65)], XRCC3 rs861539 CT+TT [OR(95% CI) 2.76(1.32-5.77)], XRCC4 rs1805377 GG [OR(95% CI) 2.07(1.10-3.90)] and rs1056503 TT [OR(95% CI) 2.17(1.16-4.07)], ERCC1 rs3212961 CC [OR(95% CI) 1.93(1.00-3.72)], RAD23B rs1805329 CC [OR(95% CI) 2.28(1.12-4.64)], and MGMT rs12917 CC, rs2308321 AA, and rs2308327 AA genotypes [OR(95% CI) 1.96(1.06-3.63), 2.02(1.09-3.75), and 2.23(1.16-4.29), respectively].	0.002638474	2014	ERCC1	19	45419065	G	T,A
rs3212961	25178586	7518	XRCC4	umls:C0024301	BeFree	The following genotypes in combination with hair dye use before 1980 were associated with FL risk: BRCA2 rs144848 AC+CC [odds ratio (OR) (95% confidence interval (CI)) 3.28(1.27-8.50)], WRN rs1346044 TT [OR(95% CI) 2.70(1.30-5.65)], XRCC3 rs861539 CT+TT [OR(95% CI) 2.76(1.32-5.77)], XRCC4 rs1805377 GG [OR(95% CI) 2.07(1.10-3.90)] and rs1056503 TT [OR(95% CI) 2.17(1.16-4.07)], ERCC1 rs3212961 CC [OR(95% CI) 1.93(1.00-3.72)], RAD23B rs1805329 CC [OR(95% CI) 2.28(1.12-4.64)], and MGMT rs12917 CC, rs2308321 AA, and rs2308327 AA genotypes [OR(95% CI) 1.96(1.06-3.63), 2.02(1.09-3.75), and 2.23(1.16-4.29), respectively].	0.002638474	2014	ERCC1	19	45419065	G	T,A
rs3212961	25178586	4255	MGMT	umls:C0024301	BeFree	The following genotypes in combination with hair dye use before 1980 were associated with FL risk: BRCA2 rs144848 AC+CC [odds ratio (OR) (95% confidence interval (CI)) 3.28(1.27-8.50)], WRN rs1346044 TT [OR(95% CI) 2.70(1.30-5.65)], XRCC3 rs861539 CT+TT [OR(95% CI) 2.76(1.32-5.77)], XRCC4 rs1805377 GG [OR(95% CI) 2.07(1.10-3.90)] and rs1056503 TT [OR(95% CI) 2.17(1.16-4.07)], ERCC1 rs3212961 CC [OR(95% CI) 1.93(1.00-3.72)], RAD23B rs1805329 CC [OR(95% CI) 2.28(1.12-4.64)], and MGMT rs12917 CC, rs2308321 AA, and rs2308327 AA genotypes [OR(95% CI) 1.96(1.06-3.63), 2.02(1.09-3.75), and 2.23(1.16-4.29), respectively].	0.003181358	2014	ERCC1	19	45419065	G	T,A
rs3212961	25178586	675	BRCA2	umls:C0024301	BeFree	The following genotypes in combination with hair dye use before 1980 were associated with FL risk: BRCA2 rs144848 AC+CC [odds ratio (OR) (95% confidence interval (CI)) 3.28(1.27-8.50)], WRN rs1346044 TT [OR(95% CI) 2.70(1.30-5.65)], XRCC3 rs861539 CT+TT [OR(95% CI) 2.76(1.32-5.77)], XRCC4 rs1805377 GG [OR(95% CI) 2.07(1.10-3.90)] and rs1056503 TT [OR(95% CI) 2.17(1.16-4.07)], ERCC1 rs3212961 CC [OR(95% CI) 1.93(1.00-3.72)], RAD23B rs1805329 CC [OR(95% CI) 2.28(1.12-4.64)], and MGMT rs12917 CC, rs2308321 AA, and rs2308327 AA genotypes [OR(95% CI) 1.96(1.06-3.63), 2.02(1.09-3.75), and 2.23(1.16-4.29), respectively].	0.003181358	2014	ERCC1	19	45419065	G	T,A
rs3751913	25279986	79415	C17orf62	umls:C0024301	GWASCAT	Genome-wide association study identifies five susceptibility loci for follicular lymphoma outside the HLA region.	0.12	2014	C17orf62	17	82447676	T	C
rs3789068	19336552	10018	BCL2L11	umls:C0024301	BeFree	Variants in BCL2L11 were strongly related to follicular lymphoma only, particularly rs3789068 (OR(AG), 1.41; 95% CI, 1.10-1.81; OR(GG), 1.65; 95% CI, 1.25-2.19; P(trend) = 0.0004).	0.002638474	2009	BCL2L11	2	111151670	A	G
rs4645959	8012955	4609	MYC	umls:C0024301	BeFree	An unusual asparagine to serine mutation at codon 11 was identified in several transformed follicular lymphomas without MYC rearrangement but not in normal tissues from patients with this mutation.	0.007524428	1994	MYC	8	127738294	A	C,G
rs4937362	25279986	5820	PVT1	umls:C0024301	BeFree	Five non-HLA loci were associated with FL risk: 11q23.3 (rs4938573, p = 5.79 × 10(-20)) near CXCR5; 11q24.3 (rs4937362, p = 6.76 × 10(-11)) near ETS1; 3q28 (rs6444305, p = 1.10 × 10(-10)) in LPP; 18q21.33 (rs17749561, p = 8.28 × 10(-10)) near BCL2; and 8q24.21 (rs13254990, p = 1.06 × 10(-8)) near PVT1.	0.120271442	2014	LOC105369568	11	128622844	T	C
rs4937362	25279986	643	CXCR5	umls:C0024301	BeFree	Five non-HLA loci were associated with FL risk: 11q23.3 (rs4938573, p = 5.79 × 10(-20)) near CXCR5; 11q24.3 (rs4937362, p = 6.76 × 10(-11)) near ETS1; 3q28 (rs6444305, p = 1.10 × 10(-10)) in LPP; 18q21.33 (rs17749561, p = 8.28 × 10(-10)) near BCL2; and 8q24.21 (rs13254990, p = 1.06 × 10(-8)) near PVT1.	0.000814326	2014	LOC105369568	11	128622844	T	C
rs4937362	25279986	2113	ETS1	umls:C0024301	BeFree	Five non-HLA loci were associated with FL risk: 11q23.3 (rs4938573, p = 5.79 × 10(-20)) near CXCR5; 11q24.3 (rs4937362, p = 6.76 × 10(-11)) near ETS1; 3q28 (rs6444305, p = 1.10 × 10(-10)) in LPP; 18q21.33 (rs17749561, p = 8.28 × 10(-10)) near BCL2; and 8q24.21 (rs13254990, p = 1.06 × 10(-8)) near PVT1.	0.000271442	2014	LOC105369568	11	128622844	T	C
rs4937362	25279986	4026	LPP	umls:C0024301	BeFree	Five non-HLA loci were associated with FL risk: 11q23.3 (rs4938573, p = 5.79 × 10(-20)) near CXCR5; 11q24.3 (rs4937362, p = 6.76 × 10(-11)) near ETS1; 3q28 (rs6444305, p = 1.10 × 10(-10)) in LPP; 18q21.33 (rs17749561, p = 8.28 × 10(-10)) near BCL2; and 8q24.21 (rs13254990, p = 1.06 × 10(-8)) near PVT1.	0.120271442	2014	LOC105369568	11	128622844	T	C
rs4937362	25279986	596	BCL2	umls:C0024301	BeFree	Five non-HLA loci were associated with FL risk: 11q23.3 (rs4938573, p = 5.79 × 10(-20)) near CXCR5; 11q24.3 (rs4937362, p = 6.76 × 10(-11)) near ETS1; 3q28 (rs6444305, p = 1.10 × 10(-10)) in LPP; 18q21.33 (rs17749561, p = 8.28 × 10(-10)) near BCL2; and 8q24.21 (rs13254990, p = 1.06 × 10(-8)) near PVT1.	0.343804516	2014	LOC105369568	11	128622844	T	C
rs4938573	25279986	2113	ETS1	umls:C0024301	BeFree	Five non-HLA loci were associated with FL risk: 11q23.3 (rs4938573, p = 5.79 × 10(-20)) near CXCR5; 11q24.3 (rs4937362, p = 6.76 × 10(-11)) near ETS1; 3q28 (rs6444305, p = 1.10 × 10(-10)) in LPP; 18q21.33 (rs17749561, p = 8.28 × 10(-10)) near BCL2; and 8q24.21 (rs13254990, p = 1.06 × 10(-8)) near PVT1.	0.000271442	2014	NA	11	118871133	C	T
rs4938573	25279986	4026	LPP	umls:C0024301	BeFree	Five non-HLA loci were associated with FL risk: 11q23.3 (rs4938573, p = 5.79 × 10(-20)) near CXCR5; 11q24.3 (rs4937362, p = 6.76 × 10(-11)) near ETS1; 3q28 (rs6444305, p = 1.10 × 10(-10)) in LPP; 18q21.33 (rs17749561, p = 8.28 × 10(-10)) near BCL2; and 8q24.21 (rs13254990, p = 1.06 × 10(-8)) near PVT1.	0.120271442	2014	NA	11	118871133	C	T
rs4938573	25279986	643	CXCR5	umls:C0024301	BeFree	Five non-HLA loci were associated with FL risk: 11q23.3 (rs4938573, p = 5.79 × 10(-20)) near CXCR5; 11q24.3 (rs4937362, p = 6.76 × 10(-11)) near ETS1; 3q28 (rs6444305, p = 1.10 × 10(-10)) in LPP; 18q21.33 (rs17749561, p = 8.28 × 10(-10)) near BCL2; and 8q24.21 (rs13254990, p = 1.06 × 10(-8)) near PVT1.	0.000814326	2014	NA	11	118871133	C	T
rs4938573	25279986	596	BCL2	umls:C0024301	BeFree	Five non-HLA loci were associated with FL risk: 11q23.3 (rs4938573, p = 5.79 × 10(-20)) near CXCR5; 11q24.3 (rs4937362, p = 6.76 × 10(-11)) near ETS1; 3q28 (rs6444305, p = 1.10 × 10(-10)) in LPP; 18q21.33 (rs17749561, p = 8.28 × 10(-10)) near BCL2; and 8q24.21 (rs13254990, p = 1.06 × 10(-8)) near PVT1.	0.343804516	2014	NA	11	118871133	C	T
rs4938573	25279986	5820	PVT1	umls:C0024301	BeFree	Five non-HLA loci were associated with FL risk: 11q23.3 (rs4938573, p = 5.79 × 10(-20)) near CXCR5; 11q24.3 (rs4937362, p = 6.76 × 10(-11)) near ETS1; 3q28 (rs6444305, p = 1.10 × 10(-10)) in LPP; 18q21.33 (rs17749561, p = 8.28 × 10(-10)) near BCL2; and 8q24.21 (rs13254990, p = 1.06 × 10(-8)) near PVT1.	0.120271442	2014	NA	11	118871133	C	T
rs568408	20952689	7124	TNF	umls:C0024301	BeFree	After stratification by common B-cell lymphoma subtypes, a significant interaction was observed for IFNGR2 (rs9808753 P(forinteraction) = .006), IL13 (rs20541 P(forinteraction) = .019), and IL7R (rs1494555 P(forinteraction) = .012) for marginal zone B-cell lymphoma; IL7R (rs1494555 P(forinteraction) = .017) for small lymphocytic lymphoma/chronic lymphocytic leukemia; and IL12A (rs568408 P(forinteraction) = .013) and TNF (1799724 P(forinteraction) = .04) for follicular lymphoma.	0.006905599	2011	IL12A;IL12A-AS1	3	159995680	G	A
rs587776632	NA	8915	BCL10	umls:C0024301	CLINVAR	NA	0.122909916	NA	BCL10	1	85267902	-	AA
rs587776633	NA	8915	BCL10	umls:C0024301	CLINVAR	NA	0.122909916	NA	BCL10	1	85270733	-	T
rs587776634	NA	8915	BCL10	umls:C0024301	CLINVAR	NA	0.122909916	NA	BCL10	1	85267788	TGCCTACTTCTAGAACA	-
rs587776635	NA	8915	BCL10	umls:C0024301	CLINVAR	NA	0.122909916	NA	BCL10	1	85267919	T	-
rs587776636	NA	8915	BCL10	umls:C0024301	CLINVAR	NA	0.122909916	NA	BCL10	1	85267931	-	A
rs587776637	NA	8915	BCL10	umls:C0024301	CLINVAR	NA	0.122909916	NA	BCL10	1	85267692	CTT	-
rs601341	17169801	4361	MRE11A	umls:C0024301	BeFree	A protective effect against follicular lymphoma was seen for the MRE11 rs601341 variant, the homozygous T allele being associated with an odds ratio (OR) of 0.50, 95% confidence interval (95% CI) 0.26 - 0.97, while a protective effect was seen for the MRE11 haplotype GCTCA (OR 0.72, 95% CI 0.53 - 0.97) for diffuse large B-cell lymphoma.	0.000271442	2006	MRE11A	11	94434611	G	A
rs6054706	23055202	81623	DEFB126	umls:C0024301	BeFree	We also observed an increased risk of FL for DEFB126 rs6054706 (allele risk OR = 1.39, P-trend = 0.033).	0.000271442	2013	NA	20	149223	C	T
rs6444305	25279986	643	CXCR5	umls:C0024301	BeFree	Five non-HLA loci were associated with FL risk: 11q23.3 (rs4938573, p = 5.79 × 10(-20)) near CXCR5; 11q24.3 (rs4937362, p = 6.76 × 10(-11)) near ETS1; 3q28 (rs6444305, p = 1.10 × 10(-10)) in LPP; 18q21.33 (rs17749561, p = 8.28 × 10(-10)) near BCL2; and 8q24.21 (rs13254990, p = 1.06 × 10(-8)) near PVT1.	0.000814326	2014	LPP	3	188582114	G	A
rs6444305	25279986	2113	ETS1	umls:C0024301	BeFree	Five non-HLA loci were associated with FL risk: 11q23.3 (rs4938573, p = 5.79 × 10(-20)) near CXCR5; 11q24.3 (rs4937362, p = 6.76 × 10(-11)) near ETS1; 3q28 (rs6444305, p = 1.10 × 10(-10)) in LPP; 18q21.33 (rs17749561, p = 8.28 × 10(-10)) near BCL2; and 8q24.21 (rs13254990, p = 1.06 × 10(-8)) near PVT1.	0.000271442	2014	LPP	3	188582114	G	A
rs6444305	25279986	5820	PVT1	umls:C0024301	BeFree	Five non-HLA loci were associated with FL risk: 11q23.3 (rs4938573, p = 5.79 × 10(-20)) near CXCR5; 11q24.3 (rs4937362, p = 6.76 × 10(-11)) near ETS1; 3q28 (rs6444305, p = 1.10 × 10(-10)) in LPP; 18q21.33 (rs17749561, p = 8.28 × 10(-10)) near BCL2; and 8q24.21 (rs13254990, p = 1.06 × 10(-8)) near PVT1.	0.120271442	2014	LPP	3	188582114	G	A
rs6444305	25279986	4026	LPP	umls:C0024301	GWASCAT	Five non-HLA loci were associated with FL risk: 11q23.3 (rs4938573, p = 5.79 × 10(-20)) near CXCR5; 11q24.3 (rs4937362, p = 6.76 × 10(-11)) near ETS1; 3q28 (rs6444305, p = 1.10 × 10(-10)) in LPP; 18q21.33 (rs17749561, p = 8.28 × 10(-10)) near BCL2; and 8q24.21 (rs13254990, p = 1.06 × 10(-8)) near PVT1.	0.120271442	2014	LPP	3	188582114	G	A
rs6444305	25279986	4026	LPP	umls:C0024301	BeFree	Five non-HLA loci were associated with FL risk: 11q23.3 (rs4938573, p = 5.79 × 10(-20)) near CXCR5; 11q24.3 (rs4937362, p = 6.76 × 10(-11)) near ETS1; 3q28 (rs6444305, p = 1.10 × 10(-10)) in LPP; 18q21.33 (rs17749561, p = 8.28 × 10(-10)) near BCL2; and 8q24.21 (rs13254990, p = 1.06 × 10(-8)) near PVT1.	0.120271442	2014	LPP	3	188582114	G	A
rs6444305	25279986	596	BCL2	umls:C0024301	BeFree	Five non-HLA loci were associated with FL risk: 11q23.3 (rs4938573, p = 5.79 × 10(-20)) near CXCR5; 11q24.3 (rs4937362, p = 6.76 × 10(-11)) near ETS1; 3q28 (rs6444305, p = 1.10 × 10(-10)) in LPP; 18q21.33 (rs17749561, p = 8.28 × 10(-10)) near BCL2; and 8q24.21 (rs13254990, p = 1.06 × 10(-8)) near PVT1.	0.343804516	2014	LPP	3	188582114	G	A
rs6457327	23025665	3126	HLA-DRB4	umls:C0024301	BeFree	In recent genome-wide association studies (GWAS) of FL, several genetic susceptibility loci have been identified on chromosome 6p21.33 (rs6457327) and 6p21.32 (rs10484561, rs2647012) in the human leukocyte antigen class I and class II regions.	0.001085767	2012	NA	6	31106253	A	C
rs6457327	20639881	285834	HCG22	umls:C0024301	GAD	[Genome-wide association study of follicular lymphoma identifies a risk locus at 6p21.32.]	0.004734064	2010	NA	6	31106253	A	C
rs6457327	19620980	285834	HCG22	umls:C0024301	GAD	[Genetic variants at 6p21.33 are associated with susceptibility to follicular lymphoma.]	0.004734064	2009	NA	6	31106253	A	C
rs735665	20639881	79827	CLMP	umls:C0024301	GAD	[Genome-wide association study of follicular lymphoma identifies a risk locus at 6p21.32.]	0.002367032	2010	GRAMD1B	11	123490689	G	A
rs735665	20639881	57476	GRAMD1B	umls:C0024301	GWASCAT	Genome-wide association study of follicular lymphoma identifies a risk locus at 6p21.32.	0.12	2010	GRAMD1B	11	123490689	G	A
rs737865	16214922	1312	COMT	umls:C0024301	BeFree	ORs for all non-Hodgkin lymphoma and follicular lymphoma among women were decreased for COMT IVS1 701A>G [rs737865; variant allele: OR, 0.53; 95% CI, 0.34-0.82; OR, 0.42; 95% CI, 0.23-0.78, respectively].	0.000271442	2005	COMT;TXNRD2	22	19942598	A	G
rs8094402	23055202	4155	MBP	umls:C0024301	BeFree	A SNP-based analysis showed that MBP rs8094402 was associated with decreased risks of overall NHL (allele risk OR = 0.72, P-trend = 0.0018), DLBCL (allele risk OR = 0.72, P-trend = 0.036), and FL (allele risk OR = 0.67, P-trend = 0.021), while MASP2 rs12711521 was associated with a decreased risk of DLBCL (allele risk OR = 0.57, P-trend = 0.0042).	0.000271442	2013	MBP	18	76995493	A	G
rs8094402	23055202	10747	MASP2	umls:C0024301	BeFree	A SNP-based analysis showed that MBP rs8094402 was associated with decreased risks of overall NHL (allele risk OR = 0.72, P-trend = 0.0018), DLBCL (allele risk OR = 0.72, P-trend = 0.036), and FL (allele risk OR = 0.67, P-trend = 0.021), while MASP2 rs12711521 was associated with a decreased risk of DLBCL (allele risk OR = 0.57, P-trend = 0.0042).	0.000271442	2013	MBP	18	76995493	A	G
rs861539	25178586	7486	WRN	umls:C0024301	BeFree	The following genotypes in combination with hair dye use before 1980 were associated with FL risk: BRCA2 rs144848 AC+CC [odds ratio (OR) (95% confidence interval (CI)) 3.28(1.27-8.50)], WRN rs1346044 TT [OR(95% CI) 2.70(1.30-5.65)], XRCC3 rs861539 CT+TT [OR(95% CI) 2.76(1.32-5.77)], XRCC4 rs1805377 GG [OR(95% CI) 2.07(1.10-3.90)] and rs1056503 TT [OR(95% CI) 2.17(1.16-4.07)], ERCC1 rs3212961 CC [OR(95% CI) 1.93(1.00-3.72)], RAD23B rs1805329 CC [OR(95% CI) 2.28(1.12-4.64)], and MGMT rs12917 CC, rs2308321 AA, and rs2308327 AA genotypes [OR(95% CI) 1.96(1.06-3.63), 2.02(1.09-3.75), and 2.23(1.16-4.29), respectively].	0.002909916	2014	KLC1;XRCC3	14	103699416	G	A
rs861539	25178586	675	BRCA2	umls:C0024301	BeFree	The following genotypes in combination with hair dye use before 1980 were associated with FL risk: BRCA2 rs144848 AC+CC [odds ratio (OR) (95% confidence interval (CI)) 3.28(1.27-8.50)], WRN rs1346044 TT [OR(95% CI) 2.70(1.30-5.65)], XRCC3 rs861539 CT+TT [OR(95% CI) 2.76(1.32-5.77)], XRCC4 rs1805377 GG [OR(95% CI) 2.07(1.10-3.90)] and rs1056503 TT [OR(95% CI) 2.17(1.16-4.07)], ERCC1 rs3212961 CC [OR(95% CI) 1.93(1.00-3.72)], RAD23B rs1805329 CC [OR(95% CI) 2.28(1.12-4.64)], and MGMT rs12917 CC, rs2308321 AA, and rs2308327 AA genotypes [OR(95% CI) 1.96(1.06-3.63), 2.02(1.09-3.75), and 2.23(1.16-4.29), respectively].	0.003181358	2014	KLC1;XRCC3	14	103699416	G	A
rs861539	25178586	4255	MGMT	umls:C0024301	BeFree	The following genotypes in combination with hair dye use before 1980 were associated with FL risk: BRCA2 rs144848 AC+CC [odds ratio (OR) (95% confidence interval (CI)) 3.28(1.27-8.50)], WRN rs1346044 TT [OR(95% CI) 2.70(1.30-5.65)], XRCC3 rs861539 CT+TT [OR(95% CI) 2.76(1.32-5.77)], XRCC4 rs1805377 GG [OR(95% CI) 2.07(1.10-3.90)] and rs1056503 TT [OR(95% CI) 2.17(1.16-4.07)], ERCC1 rs3212961 CC [OR(95% CI) 1.93(1.00-3.72)], RAD23B rs1805329 CC [OR(95% CI) 2.28(1.12-4.64)], and MGMT rs12917 CC, rs2308321 AA, and rs2308327 AA genotypes [OR(95% CI) 1.96(1.06-3.63), 2.02(1.09-3.75), and 2.23(1.16-4.29), respectively].	0.003181358	2014	KLC1;XRCC3	14	103699416	G	A
rs861539	25178586	7517	XRCC3	umls:C0024301	BeFree	The following genotypes in combination with hair dye use before 1980 were associated with FL risk: BRCA2 rs144848 AC+CC [odds ratio (OR) (95% confidence interval (CI)) 3.28(1.27-8.50)], WRN rs1346044 TT [OR(95% CI) 2.70(1.30-5.65)], XRCC3 rs861539 CT+TT [OR(95% CI) 2.76(1.32-5.77)], XRCC4 rs1805377 GG [OR(95% CI) 2.07(1.10-3.90)] and rs1056503 TT [OR(95% CI) 2.17(1.16-4.07)], ERCC1 rs3212961 CC [OR(95% CI) 1.93(1.00-3.72)], RAD23B rs1805329 CC [OR(95% CI) 2.28(1.12-4.64)], and MGMT rs12917 CC, rs2308321 AA, and rs2308327 AA genotypes [OR(95% CI) 1.96(1.06-3.63), 2.02(1.09-3.75), and 2.23(1.16-4.29), respectively].	0.008001298	2014	KLC1;XRCC3	14	103699416	G	A
rs861539	25178586	7518	XRCC4	umls:C0024301	BeFree	The following genotypes in combination with hair dye use before 1980 were associated with FL risk: BRCA2 rs144848 AC+CC [odds ratio (OR) (95% confidence interval (CI)) 3.28(1.27-8.50)], WRN rs1346044 TT [OR(95% CI) 2.70(1.30-5.65)], XRCC3 rs861539 CT+TT [OR(95% CI) 2.76(1.32-5.77)], XRCC4 rs1805377 GG [OR(95% CI) 2.07(1.10-3.90)] and rs1056503 TT [OR(95% CI) 2.17(1.16-4.07)], ERCC1 rs3212961 CC [OR(95% CI) 1.93(1.00-3.72)], RAD23B rs1805329 CC [OR(95% CI) 2.28(1.12-4.64)], and MGMT rs12917 CC, rs2308321 AA, and rs2308327 AA genotypes [OR(95% CI) 1.96(1.06-3.63), 2.02(1.09-3.75), and 2.23(1.16-4.29), respectively].	0.002638474	2014	KLC1;XRCC3	14	103699416	G	A
rs861539	25178586	2067	ERCC1	umls:C0024301	BeFree	The following genotypes in combination with hair dye use before 1980 were associated with FL risk: BRCA2 rs144848 AC+CC [odds ratio (OR) (95% confidence interval (CI)) 3.28(1.27-8.50)], WRN rs1346044 TT [OR(95% CI) 2.70(1.30-5.65)], XRCC3 rs861539 CT+TT [OR(95% CI) 2.76(1.32-5.77)], XRCC4 rs1805377 GG [OR(95% CI) 2.07(1.10-3.90)] and rs1056503 TT [OR(95% CI) 2.17(1.16-4.07)], ERCC1 rs3212961 CC [OR(95% CI) 1.93(1.00-3.72)], RAD23B rs1805329 CC [OR(95% CI) 2.28(1.12-4.64)], and MGMT rs12917 CC, rs2308321 AA, and rs2308327 AA genotypes [OR(95% CI) 1.96(1.06-3.63), 2.02(1.09-3.75), and 2.23(1.16-4.29), respectively].	0.002638474	2014	KLC1;XRCC3	14	103699416	G	A
rs861539	25178586	5887	RAD23B	umls:C0024301	BeFree	The following genotypes in combination with hair dye use before 1980 were associated with FL risk: BRCA2 rs144848 AC+CC [odds ratio (OR) (95% confidence interval (CI)) 3.28(1.27-8.50)], WRN rs1346044 TT [OR(95% CI) 2.70(1.30-5.65)], XRCC3 rs861539 CT+TT [OR(95% CI) 2.76(1.32-5.77)], XRCC4 rs1805377 GG [OR(95% CI) 2.07(1.10-3.90)] and rs1056503 TT [OR(95% CI) 2.17(1.16-4.07)], ERCC1 rs3212961 CC [OR(95% CI) 1.93(1.00-3.72)], RAD23B rs1805329 CC [OR(95% CI) 2.28(1.12-4.64)], and MGMT rs12917 CC, rs2308321 AA, and rs2308327 AA genotypes [OR(95% CI) 1.96(1.06-3.63), 2.02(1.09-3.75), and 2.23(1.16-4.29), respectively].	0.002638474	2014	KLC1;XRCC3	14	103699416	G	A
rs9808753	20952689	7124	TNF	umls:C0024301	BeFree	After stratification by common B-cell lymphoma subtypes, a significant interaction was observed for IFNGR2 (rs9808753 P(forinteraction) = .006), IL13 (rs20541 P(forinteraction) = .019), and IL7R (rs1494555 P(forinteraction) = .012) for marginal zone B-cell lymphoma; IL7R (rs1494555 P(forinteraction) = .017) for small lymphocytic lymphoma/chronic lymphocytic leukemia; and IL12A (rs568408 P(forinteraction) = .013) and TNF (1799724 P(forinteraction) = .04) for follicular lymphoma.	0.006905599	2011	IFNGR2	21	33415005	A	G

GWASdb Annotation(Total Genotypes:0)
(Waiting for update.)

GWASdb Snp Trait(Total Genotypes:0)
(Waiting for update.)

Mapped by lexical matching(Total Items:1)
HP ID	HP Name	MP ID	MP Name	Annotation
HP:0004370	Abnormality of temperature regulation	MP:0001777	abnormal body temperature homeostasis;HP:0002585	Abnormality of the peritoneum

Mapped by homologous gene(Total Items:1)
HP ID	HP Name	MP ID	MP Name	Annotation
HP:0000975	Hyperhidrosis	MP:0000010	abnormal abdominal fat pad morphology;HP:0004370	Abnormality of temperature regulation

Chemical(Total Drugs:3)
CUI	ChemicalName	ChemicalID	CasRN	DiseaseName	DiseaseID	DirectEvidence	PubMedIDs
C0024301	ifosfamide	D007069	3778-73-2	lymphoma, follicular	MESH:D008224	therapeutic	11571709
C0024301	lindane	D001556	58-89-9	lymphoma, follicular	MESH:D008224	marker/mechanism	25337994
C0024301	mitoxantrone	D008942	65271-80-9	lymphoma, follicular	MESH:D008224	therapeutic	11571709

FDA approved drug and dosage information(Total Drugs:0)
(Waiting for update.)

FDA labeling changes(Total Drugs:0)
(Waiting for update.)